Home
  >  
Section 35

EurekaMag Full Text Articles Chapter 34,869



References:

Marinella, M.A. 1999: Erythema multiforme possibly due to phenytoin. Annals of PharmacoTherapy 33(6): 748
Benjamin, S.; Mueller, B.A. 1999: Erythema multiforme secondary to amoxicillin/clavulanic acid exposure. Annals of PharmacoTherapy 33(1): 109-110
Padial, M.A.; Barranco, P.; Lopez-Serrano, C. 2000: Erythema multiforme to vancomycin. Allergy 55(12): 1201
Forman, R.; Koren, G.; Shear, N.H. 2002: Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Safety 25(13): 965-972
Lengrand, F.; Tellart, A.S.; Segard, M.; Dejobert, Y.; Thomas, P. 2001: Erythema multiforme-like eruption: an unusual presentation of primula contact allergy. Contact Dermatitis 44(1): 35
Horiuchi, Y.; Kunii, T.; Hidaka, Y.; Ogata, K.; Urata, Y. 1999: Erythema multiforme-like eruptions associated with adenocarcinoma of the stomach in a patient with generalized prurigo simplex of two years duration. Journal of Dermatology 26(4): 264-266
Jappe, U.; Petzoldt, D. 2001: Erythema multiforme-like eruptions following allergic contact dermatitis to a paint-on tattoo due to a p-phenylene diamine contact hypersensitivity. Allergy 56(Suppl 68): 183
Lee, J.-Y.; Lee, E.-S. 2003: Erythema multiforme-like lesions in syphilis. British Journal of Dermatology 149(3): 658-660
Peter, R.; Banyai, T. 2001: Erythema nodosum revealing oculoglandular tularemia. Dermatology 202(1): 79-80
Jappe, U.; Hausen, B.M.; Petzoldt, D. 2001: Erythema-multiforme-like eruption and depigmentation following allergic contact dermatitis from a paint-on henna tattoo, due to para-phenylenediamine contact hypersensitivity. Contact Dermatitis 45(4): 249-250
Pérez, A.; Cabrerizo, S.; de Barrio, M.; Díaz, M.P.; Herrero, T.; Tornero, P.; Baeza, M.L. 2001: Erythema-multiforme-like eruption from amoxycillin and allopurinol. Contact Dermatitis 44(2): 113-114
Silvestre, J.F.; Betlloch, I.; Guijarro, J.; Albares, M.P.; Vergara, G. 2001: Erythema-multiforme-like eruption on the application site of a nitroglycerin patch, followed by widespread erythema multiforme. Contact Dermatitis 45(5): 299-300
Akita, H.; Washimi, Y.; Akamatsu, H.; Fukui, Y.; Matsunaga, K. 2001: Erythema-multiforme-like occupational contact dermatitis due to bisphenol a. Contact Dermatitis 45(5): 305
Das, S.; Lloyd, J.J.; Farr, P.M. 2000: Erythemal response to broad-band and narrow-band UVB. British Journal of Dermatology 142(3): 622-623
Lloret, P.; Redondo, P.; Vazquez-Doval, F.J. 2004: Erythematous lump on the abdomen. British Journal of Dermatology 150(4): 769
Monastero, R.; Lopez, G.; Mannino, M.; Camarda, R. 2001: Erythematous maculopapular eruption due to rivastigmine therapy. American Journal of Medicine 111(7): 583-584
Motta-Silva, A.C.; Aleva, N.A.; Chavasco, J.K.; Armond, M.ôn.C.; França, J.P.; Pereira, L.J.é 2010: Erythematous oral candidiasis in patients with controlled type Ii diabetes mellitus and complete dentures. Mycopathologia 169(3): 215-223
Li, L.F. 1999: Erythematous skin reaction to subcutaneous injection of ribonucleic acid. Contact Dermatitis 41(4): 239
Lee, J.S.; Komaki, R.; Touroutoglou, N.; Delclos, M.; Fox, N.; Glisson, B.S.; Perez Soler, R.; Fossella, F.V.; Khuri, F.R.; Hong, W.K. 1999: Erythopoietin plus iron supplement prevents significant anemia during concurrent chemo-radiation therapy in patients with locally-advanced inoperable non-small cell lung cancer. Proceedings of the American Association for Cancer Research 40: 642
D.S.deleer, J.W.lly Ghislain Corneel; Gonze, M.H.nri Andre 1999: Erythritol compositions. Official Gazette of the United States Patent and Trademark Office Patents 1227(4)
D.Cock, Petrus Wilhelmus Hubertus Antonius 2000: Erythritol containing beverage imparting a cooling taste sensation. Official Gazette of the United States Patent and Trademark Office Patents 1234(4)
Lin, S.J.; Wen, C.Y.; Huang, C.C.; Chu, W.S. 2002: Erythritol--producing Moniliella strains. Official Gazette of the United States Patent and Trademark Office Patents 1262(4)
Lin, S.J.; Wen, C.Y.; Hsu, W.H.; Liou, G.Y.; Chu, W.S. 2001: Erythritol-producing yeast strains. Official Gazette of the United States Patent and Trademark Office Patents 1251(2)
Tsuji, T.; Sakata, T.; Ikeuchi, Y.; Oguni, S.'ichiro 2003: Erythroblast diagnostic flow-cytometry method and reagents. Official Gazette of the United States Patent and Trademark Office Patents 1277(3)
Palumbo, R.; Bondanini, F.; Galliani, M.; Fumagalli, E.; Vitaliano, E.; Chicca, S.; Colonnello, M.; Bonello, M.; Vasselli, C.; Paone, A. 2002: Erythrocite defence mechanisms against free radical toxicity in three different dialysis techniques. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 239A
Friedman, D.F.; Jawad, A.F.; Martin, M.B.; Horiuchi, K.; Mitchell, C.F.; Cohen, A.R. 2003: Erythrocytapheresis to reduce iron loading in thalassemia. Blood 102(11): 121a
Hord, J.D.; Shaw, C.; Kasunick, L.; Sapatnekar, S. 2003: Erythrocytapheresis with indwelling central venous catheters in children with sickle cell disease on a chronic transfusion program. Pediatric Research 53(4 Part 2): 279A
Cuffari, C.; Hunt, S.; Harris, M.; Bayless, T. 2000: Erythrocyte 6-thioguanine metabolite levels predict clinical responsiveness to therapy in IBD. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A785
Murdoch, S.D.; Collighan, N.; Bellamy, M.C. 2001: Erythrocyte ATP concentration and red cell hypochromasia in critical illness. British Journal of Anaesthesia 86(2): 312P-313P
Zimran, A.; Bashkin, A.; Rotstein, R.; Rozenblat, M.; Avitzour, D.; Mardi, T.; Shapira, I.; Rudensky, B.; Elstein, D.; Berliner, S. 2002: Erythrocyte Adhesiveness / Aggregation Test as a New Marker for Gaucher Disease Correlation with Inflammatory Sensitive Proteins. Blood 100(11): Abstract No. 3624
Moulds, J.M.; Roberts, S.; Tew, M.; Reveille, J.; Alarcon, G. 2000: Erythrocyte CR1 levels do not correlate with disease activity in Hispanic SLE patients. Immunopharmacology 49(1-2): 29
Fraquelli, M.; Novembrino, C.; Buccianti, G.; Bamonti Catena, F.; Rosina, M.; Conte, D.; Fasano, M.A.; Ciani, A.; De Franceschi, M. 1999: Erythrocyte Ferritin is a promising tool in iron-related disorders. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S506
Lauf, P.K.; Zhang, J.; Delpire, E.; Fyffe, R.E.W.; Mount, D.B.; Adragna, N.C. 2000: Erythrocyte K-Cl cotransport and beyond Implications of immunochemical evidence of two KCC isoforms in HK and LK sheep. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 126A(Suppl 1): S89
Ferro, M.; Boero, R.; Quarello, F.; Sacchetti, C.; Cerutti, F. 2000: Erythrocyte Na,Li countertransport and risk of nephropathy in type I diabetes A twelve years follow-up. Nephrology Dialysis Transplantation 15(9): A104
Vareesangthip, K.; Nimmannit, S.; Vanichakarn, S.; Pidetcha, P.; Ong, A.Y.oth, L. 1999: Erythrocyte Na/Li countertransport in cyclosporine A treated renal transplant patients. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 767A
Giavarina, D.; Dorizzi, R.M.; Soffiati, G. 2002: Erythrocyte Sedimentation Rate Reference limits based on patients database. Clinical Chemistry 48(6 Suppl): A159
Roh, H.K.; Kang, J.H.; Kwon, Y.S.; Leem, J.H.; Kim, J.S. 2003: Erythrocyte acetylcholinesterase activities according to age in Koreans. Journal of Toxicology. Clinical Toxicology 41(5): 735
Vayá, A.; Breña, S.; Réganon, E.; Vila, V.; Martinez-Sales, V.; Contreras, M.T.; Zorio, E.; Corella, D.; Aznar, J. 2004: Erythrocyte aggregation and -455G/A polymorphism of the beta-fibrinogen gene in survivors of acute myocardial infarction. Thrombosis and Haemostasis 92(1): 223-224
Caimi, G.; Canino, B.; Romano, A.; Catania, A.; Lo Presti, R. 2000: Erythrocyte aggregation and erythrocyte membrane properties in type 2 diabetes mellitus and in vascular atherosclerotic disease. Thrombosis and Haemostasis 83(3): 516-517
Kayar, E.; Ataus, S.; Colakkaya, M.; Kucukatay Bor, M.; Balkan, S.; Baskurt, O.K. 1999: Erythrocyte aggregation in acute stage of ischemic stroke Importance of cellular factors. Biorheology 36(1-2): 81
Azaceta, G.; Romero, S.; Azconal, M.; Moreno, J.A.; Olave, T.; Varo, M.J.; Sola, C.; Arruga, A.; Palomera, L.; Gutierrez, M. 1999: Erythrocyte aggregation in chronic venous insufficiency. Biorheology 36(1-2): 104-105
Mchedlishvili, G. 2002: Erythrocyte aggregation in the microcirculation. Biorheology 39(5): 658
Levin, I.; Helpman, L.; Maslovitz, S.; Pauzner, D.; Shapira, I.; Gamzu, R.; Almog, B. 2006: Erythrocyte aggregation is increased in preterm premature rupture of the membranes. European Journal of Obstetrics Gynecology and Reproductive Biology 125(2): 199-201
Amirante, A.; Bertoluzzo, S.M.; Bertoluzzo, M.G.; Rigatuso, R.; Quattrin, F.E.; Spengler, M.I. 1999: Erythrocyte aggregation of red cells incubated in human serum albumin denatured by radiation. Biorheology 36(1-2): 103-104
Makita, J.; Oishi, N.; Sugimoto, Y.; Bessho, R.; Takahashi, Y.; Akagi, Y.; Maekawa, K.; Tanimoto, T. 1999: Erythrocyte aldose reductase level and the incidence of diabetic retinopathy in Japanese NIDDM patients. IOVS Investigative Ophthalmology and Visual Science 40(4): S311
Ludany, A.; Koszegi, T.; Bogner, P.; Kellermayer, M. 2001: Erythrocyte and platelet size, number and ATP content in different mammalian species. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S279
Allen, J.W.; Collins, B.W.; Lori, A.; Afshari, A.J.; George, M.H.; DeAngelo, A.B.; Fuscoe, J.C. 2000: Erythrocyte and spermatid micronucleus analyses in mice chronically exposed to potassium bromate in drinking water. Environmental and Molecular Mutagenesis 36(3): 250-253
Bakheit, K.H.; Ghebremeskel, K.; Zaiger, G.; Elbashir, M.I.; Adam, I. 2010: Erythrocyte antioxidant enzymes and plasma antioxidant vitamins in Sudanese women with pre-eclampsia. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 30(2): 147-150
Prezelj, M.; Briski, A.; Krsnik, M.; Osredkar, J.; Horvat, M.; Kobal, A. 2001: Erythrocyte antioxidant enzymes, lipid hydroperoxides and selenium in mercury mine workers. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S124
Farkas, K.; Sasvari, M.; Szaleczki, E.; Pusztai, P.; Somogyi, A. 1999: Erythrocyte antioxidant status of type 2 diabetic patients with and without complications. Diabetologia 42(Suppl 1): A327
M.N.rhalim, S.; Tri Hanggono, A.; Amnah, R. 2000: Erythrocyte as a reservoir for glucose. Vox Sanguinis 78(Suppl 1): P310
Vanbuskirk, K.M.; Fraser, T.S.; Adams, J.H. 1999: Erythrocyte binding activity of Plasmodium yoelii MAEBL. American Journal of Tropical Medicine and Hygiene 61(3 Suppl): 491
Shi, Q.; Zhang, D.; Nanavati, P.A.; Mistry, A.; Burns, J.M.J. 2003: Erythrocyte binding activity of Plasmodium yoelii merozoite surface protein-8 involves determinants outside of the protective C-terminal EGF-like domains. Experimental Parasitology 105(1): 65-66
Maier, A.G.; Baum, J.; Conway, D.; Reeder, J.; Cowman, A.F. 2003: Erythrocyte binding antigen mediated invasion pathways of Plasmodium falciparum Attraction and exploitation. Experimental Parasitology 105(1): 54
Fuhrmann, S.R.; Narum, D.L.; Liang, H.; Sim, B.K.L. 1999: Erythrocyte binding profile of a chimeric Plasmodium falciparum and P vivax erythrocyte binding ligand. American Journal of Tropical Medicine and Hygiene 61(3 Suppl): 481
Charlton, C.J.; Robertson, A.; Martin, D.J.; Skinner, N.D.; Smith, B.H.E.; Harper, E.J. 2000: Erythrocyte catalase activity in cats. FASEB Journal 14(4): A518
Charlton, C.J.; Robertson, A.D.; Martin, D.J.; Smith, B.H.E.; Harper, E.J. 2000: Erythrocyte catalase activity in dogs. FASEB Journal 14(4): A518
Saibara, T.; Okumiya, T.; Jiao, Y.; Sugiura, T.; Ono, M.; Matsuura, Y.; Iwasaki, S.; Maeda, T.; Onishi, S. 2000: Erythrocyte creatine as a non-isotope indicator of hypersplenism in cirrhosis. Journal of Hepatology 32(Suppl 2): 152
Takemoto, Y.; Okumiya, T.; Tsuchida, K.; Nakatani, T.; Yamamoto, K. 2000: Erythrocyte creatine as an index of the erythrocyte life span and erythropoiesis. Nephron 86(4): 513-514
Uretman, P.; Temiz, A.; Baskurt, O.K.; Biberoglu, S. 1999: Erythrocyte deformability changes in impaired glucose tolerance. Biorheology 36(1-2): 90
Vikulov, A.D.; Mel'nikov, A.A.; Osetrov, I.A. 1999: Erythrocyte deformability in athletes. Fiziologiia Cheloveka 25(4): 136-139
Popescu (Hategan), A.L.; Law, R.J.; Discher, D.E. 2002: Erythrocyte deformation in atomic force microscopy. Biophysical Journal 82(1 Part 2): 53a-54a
Bashirova, R.M.; Gareev, E.M. 1999: Erythrocyte electrophoretic characteristics and volume in neonates experienced acute hypoxia at birth. Fiziologiya Cheloveka 25(6): 126-128
Schulte, M.L.; Wood, J.D.; Hudetz, A.G. 2001: Erythrocyte flow in cerebral capillaries during cortical electrical stimulation. FASEB Journal 15(4): A37
Hudetz, A.G. 2001: Erythrocyte flow in the cerebral capillary network during ischemia and hypoxemia Observations with intravital microscopy. Fukuuchi, Y , Tomita, M , Koto, A Keio University Symposia for Life Science and Medicine Ischemic blood flow in the brain 304-312
Clifford, A.J.; Lin, Y.; Ho, C.C.; Noceti, E.M.; Joy, A.B.; Block, T.; Block, G. 2004: Erythrocyte folate concentrations and folate intake in low-income women. FASEB Journal 18(4-5): Abstract 588
Kovi, D.; Rinehardt, K.F.; Axtell, R.S.; Upson, D.; Weitzner, J.M.; Klein, S.V.; Quill, T. 2003: Erythrocyte glucose uptake during graded swimming. Medicine and Science in Sports and Exercise 35(5 Suppl): S367
Shamansurova, Z.M.; Turakulov, Y.K.H.; Akbarov, Z.S.; Normukhamedova, N.F.; Akhmedova, M.; Kim, A.A. 2000: Erythrocyte glucose uptake increase in patients with diabetes mellitus. Biochemical Society Transactions 28(5): A161
Chittiprol, S.; Arathi; Bhat, S.; Nair, S.R.; Ponduri, M.; Rao, A.; Raja, A.; Rao, S. 2003: Erythrocyte glutathione and serum glutathione-S-transferase in patients with brain tumors. Clinica Chimica Acta; International Journal of Clinical Chemistry 333(1): 97-99
Jagger, J.; Mccullen, S.; Yun, C.; Ellis, C. 2004: Erythrocyte hemodynamics as a function of the local O2 environment in the EDL muscle of the rat. FASEB Journal 18(4-5): Abstract 433
Ziegler, E.E.; Haschke, F.; Serfass, R.E.; Carrie Fassler, A.L.; Nelson, S.E.; Jeter, J.M. 2000: Erythrocyte incorporation of iron in infants fed a modified whey formula with iron concentration 4 mg/L. JPGN 31(Suppl 2): S171
Gomez-Escobar, N.; Amambua-Ngwa, A.; Walther, M.; Okebe, J.; Ebonyi, A.; Conway, D.J. 2010: Erythrocyte invasion and merozoite ligand gene expression in severe and mild Plasmodium falciparum malaria. Journal of Infectious Diseases 201(3): 444-452
Orlov, S.; Gossard, F.; Pausova, Z.; Gaudet, D.; Tremblay, J.; Kotchen, T.; Cowley, A.; Larochelle, P.; Hamet, P. 2000: Erythrocyte ion transport in sib pairs Impact of gender, race and hypertension. Journal of Hypertension 18(Suppl 4): S207
Sevinc, M.; Ugurtas, I.H.; Yildirimhan, H.S. 2000: Erythrocyte measurements in Lacerta rudis. Turkish Journal of Zoology 24(2): 207-209
Shi Lin Jie; Chen Chang Hua; Luo Tuan Lian 2000: Erythrocyte membrance adenosine triphosphatase activity determination in patients with TCM Liver-Yin deficiency syndrome. Hunan Yike Daxue Xuebao 25(5): 509
Yalouris, A.G.; Kantartzis, K.; Loukidelis, G.; Dimitriadis, G.; Raptis, S.A. 2003: Erythrocyte membrane cholesterol concentration and differences according to cellular age in healthy and diabetic subjects. Diabetes and Metabolism 29(Hors serie 2): 4S317
Memon, L.; Spasojevic Kalimanovska, V.; Jovic, P.; Spasic, S.; Stanojevic, N. 2001: Erythrocyte membrane cholesterol in relation to plasma lipids, body mass index and blood pressure in male blood donors. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S274
Umudum, F.Z.; Yucel, O.; Sahin, Y.N.; Bakan, E. 2001: Erythrocyte membrane glycation and sodium and potassium levels in type II diabetics. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S396
Suchánková, G.; Vlasáková, Z.; Zicha, J.; Vokurková, M.; Dobesová, Z.; Pelikánová, T. 2002: Erythrocyte membrane ion transport in offspring of hypertensive parents: effect of acute hyperinsulinemia and relation to insulin action. Annals of the new York Academy of Sciences 967: 352-362
Nishiki, K.; Nagase, S.; Hirayama, A.; Gotoh, M.; Takemura, K.; Ueda, A.; Aoyagi, K.; Suzuki, H.; Terao, J.; Koyama, A. 1999: Erythrocyte membrane lipid peroxidation is increased in severe renal anaemic patients and serum cholesteryl ester hydroperoxide is reduced by erythropoietin administration. Nephrology Dialysis Transplantation 14(9): A263
Caimi, G.; Canino, B.; Vaccaro, F.; Montana, M.; Lo Presti, R. 1999: Erythrocyte membrane protein lateral mobility in chronic renal failure. Nephron 81(4): 449
Pekpak, M.; Ercan, M.; Konukoglu, D.; Serdengecti, K.; Erek, E. 2001: Erythrocyte membrane stiffness or red cell deformability, blood and plasma viscosity in proteinuric patients. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 504A
Rybczynska, M.; Pawlak, A.L. 1999: Erythrocyte membranes of ataxia telangi-ectasia patients and heterozygotes display the high content of PKC alpha and low PKC zeta. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S150
Albertini, C.; Piatti, E.; Uguccioni, F.; Rocchi, M.; Baldoni, F.; Teodori, L.; Accorsi, A. 2004: Erythrocyte morphology automated analysis Proposal for a predictive tool of essential hypertension diagnosis. Cytometry 59A(1): 139
Bakheit, K.H.; Ghebremeskel, K.; Pol, K.; Elbashir, M.I.; Adam, I. 2010: Erythrocyte omega-3 and omega-6 fatty acids profile in Sudanese women with pre-eclampsia. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 30(2): 151-154
Adenkola,A.Y.; Ayo,J.O.; Sackey,A.K.B.; Adelaiye,A.B. 2010: Erythrocyte osmotic fragility of pigs administered ascorbic acid and transported by road for short-term duration during the harmattan season. African Journal Of Biotechnology: 2, 226-233
Maltsev, V.P.; Tarasov, P. 2004: Erythrocyte osmotic lysis measured with scanning flow cytometer. Cytometry 59A(1): 144
Jakic, M.; Zibar, L.; Cetina, N.; Wagner, J.; Barbic, J.; Mihaljevic, D. 2000: Erythrocyte osmotic resistance and erythropoietin therapy in hemodialysis treated patients. Nephrology Dialysis Transplantation 15(9): A160
Kuchay, S.M.; Cioffi, A.; Chishti, A.H. 2002: Erythrocyte p55 Forms a Tripartite Complex with Protein 42 and CD47 Adhesion Receptor. Blood 100(11): Abstract No. 2586
Barton, J.C.; Bertoli, L.F.; Rothenberg, B.E. 2001: Erythrocyte parameters in hemochromatosis. Official Gazette of the United States Patent and Trademark Office Patents 1248(5)
Ranic, M.; Ristic, V.; Tepsic, V.; Vrbaski, S.; Perunicic, G.; Pljesa, S. 2001: Erythrocyte phospholipids fatty acid composition in chronic hemodialysis patients. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S290
Walczak, M.; Fogel, W.A.; Ciechanowski, K.; Sasiak, K.; Petriczko, E. 1999: Erythrocyte polyamine concentrations in preterm versus term neonates and at the end of the first year. Hormone Research 51(Suppl 2): 25
Garnier, P.E.; Bottari, S.; Bayle, M.; Bosson, J.L.; De Fraipont, F.; Bost, M. 2000: Erythrocyte polyamine responses to insulin in short children in relation to growth hormone. Hormone Research 53(Suppl 2): 36
Perkov, S.; Flegar Mestric, Z.; Papa, B. 2001: Erythrocyte porphobilinogen deaminase activity in the diagnosis of acute intermittent porphyria. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S199
Matteucci, E.; Cinapri, V.; Quilici, S.; Forotti, G.; Giampietro, O. 2000: Erythrocyte proton and electron paths in type 1 diabetes mellitus. Diabetes Research and Clinical Practice 50(Suppl 1): S136
Mei, Z.; Cogswell, M.E.; Parvanta, I.; Grummer Strawn, L.M. 2002: Erythrocyte protoporphyrin or hemoglobin Which is a better screening test for iron deficiency in children and women?. American Journal of Epidemiology 155(11 Suppl): S55
Jurka, A.; Mazarevica, G.; Tirzite, D.; Krasnakova, I.; Tretjakovs, P.; Zvaigzne, A.; Pirags, V. 2001: Erythrocyte refractive index, membrane fluidity and plasma antioxidant status in diabetic patients. Diabetologia 44(Suppl 1): A320
Komorowska, M&lstrok:gorzata.; Cuissot, A.; Czarnolecki, A.; Bialas, W. 2001: Erythrocyte Response to Near Infrared Radiation. Cellular and Molecular Biology Letters 6(2): 212
Hernandez, G.; Gayol, M.C.; Rasia, M. 1999: Erythrocyte rheology in a diabetes, obesity and hypertension rat genetic model. Biorheology 36(1-2): 91
Weiskopf, R.B. 2000: Erythrocyte salvage during cesarean section. Anesthesiology 92(6): 1519-1522
Prabha, B.; Singh, C. 2000: Erythrocyte sedimentation rate and blood clotting time in crossbred preparturient cows and its calves. Indian Journal of Animal Sciences 70(6): 594-595
Shutov, A.; Kondratyeva, N. 2002: Erythrocyte sedimentation rate and stroke volume/pulse pressure ratio in non-diabetic pre-dialysis patients. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 244
Vanasek, T.; Dulicek, P.; Hulek, P.; Loudova, P.; Krajina, A.; Zizka, J.; Fejfar, T.; Pozler, O.; Lojik, M.; Volfova, M.; Hruba, I. 2001: Erythrocyte sedimentation rate as diagnostic test for Budd-Chiari syndrome?. Journal of Hepatology 34(Suppl 1): 64
Hengstenberg, W.R. 1999: Erythrocyte sedimentation rate control. Official Gazette of the United States Patent and Trademark Office Patents 1218(4): 3096
Vareesangthip, K.; Shayakul, C.; Nitiyanant, W.; Panthongdee, W.; Ong, A.Y.oth, L. 2002: Erythrocyte sodium lithium countertransport and membrane fluidity in diabetic nephropathy in Thailand. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 689A
Vareesangthip, K.; Pidetcha, P.; Hanlakorn, P.; Suwannaton, L.; Ong, A.Y.oth, L. 2001: Erythrocyte sodium lithium countertransport in idiopathic membranous nephropathy. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 42A
Matteucci, E.; Rizvi, S.I.; Giampietro, O. 2001: Erythrocyte sodium/hydrogen exchange inhibition by (-) epicatechin. Cell Biology International 25(8): 771-776
Rodrigues, F.P.M.; Berezin, A.; Percario, S.; Pachi, P. 2000: Erythrocyte superoxide dismutase activity in premature babies with and without Hyaline Membrane Disease. Pediatric Research 47(4 Part 2): 374A
Zupanic, D.; Cepelak, I. 1999: Erythrocyte superoxide dismutase in children with bronchial obstruction. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S425
Vera, C.; Lao, J.; Lin, J.J.C.; Sung, L.A. 2000: Erythrocyte tropomyosin-binding site on human tropomodulin. FASEB Journal 14(4): A100
Soldati, L.; Adamo, D.; Manunta, P.; Stella, P.; Zerbi, S.; Ciurlino, D.; Cravedi, P.; Bigatti, G.; Bianchi, G.; Vezzoli, G. 1999: Erythrocyte voltage-dependent calcium influx is associated with cardiac disorders in hemodialyzed patients. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 304A
Quintana, E.S.; Bernstein, M.H. 1999: Erythrocyte volumes in hypoxic pigeons. FASEB Journal 13(5 Part 2): A745
Brugnara, C.; De Franceschi, L.; Beuzard, Y. 2001: Erythrocyte-active agents and treatment of sickle cell disease. Seminars in Hematology 38(4): 324-332
Sprague, R.S.; Ellsworth, M.L.; Stephenson, A.H.; Olearczyk, J.J.; Lonigro, A.J. 2002: Erythrocyte-derived ATP produces vasodilation in the rabbit pulmonary circulation via a nitric oxide-dependent mechanism. FASEB Journal 16(4): A127
Selvetella, G.; Maffei, A.; Lembo, G. 2003: Erythrocyte-derived depressing factor: a novel cardiovascular player?. Journal of Hypertension 21(6): 1087-1088
Tadayoni, R.; Paques, M.; Laurent, P.; Gaudric, A.; Vicaut, E. 2000: Erythrocytes and leukocytes dynamics in retinal capillaries of diabetic mice. IOVS Investigative Ophthalmology and Visual Science 41(4): S408
Dumez, H.; Highley, M.; Guetens, G.; De Boeck, G.; Hanauske, A.; van Oosterom, A.T.; Maes, R.A.; de Bruijn, E.A.; Harper, P. 2001: Erythrocytes and the transfer of anticancer drugs and metabolites: a possible relationship with therapeutic outcome. Seminars in Oncology 28(2 Suppl 8: 24-28
Corinti, S.; Chiarantini, L.; Magnani, M.; Girolomoni, G. 2001: Erythrocytes efficiently deliver Tat antigen to human dendritic cells for initiation of specific type 1 immune responses in vitro. Journal of Investigative Dermatology 117(4): 1012
Melder, R.J.; Yuan, J.; Munn, L.L.; Jain, R.K. 2000: Erythrocytes enhance lymphocyte rolling and arrest in vivo. Microvascular Research 59(2): 316-322
Prohaska, J.R.; West, E.C. 2004: Erythrocytes from Copper-Deficient Mice and Rats have Lower Cu,Zn-superoxide dismutase but Higher Copper Chaperone Levels. FASEB Journal 18(4-5): Abstract 603
Wautier, M.P.; Boulanger, E.; Wautier, J.L. 2002: Erythrocytes from diabetic patients adhere to endothelium and potentiate leukocyte adhesion molecule expression. Biorheology 39(5): 659
Valles, J.; Santos, M.T.; Martinez, M.; Moscardo, A.; Gomez Biedma, S.; Pinon, M.; Aznar, J. 2000: Erythrocytes increase GPIIbIIIa receptor activation and secretion in recruiting platelets. Haemostasis 30(Suppl 1): 78
Liang, G.E.; Lonigro, A.J.; Olearczyk, J.J.; Stephenson, A.H.; Sprague, R.S. 2004: Erythrocytes of Humans with Cystic Fibrosis Fail to Stimulate Nitric Oxide Synthesis in the Isolated Rabbit Lung. FASEB Journal 18(4-5): Abstract 220
Kwiatkowska, E.; Bober, J.; Kedzierska, K.; Ciechanowski, K.; Myslak, M.; Olszewska, M. 2002: Erythrocytes sodium-proton exchanger activity in chronic hemodialysis patients. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 273
Van Der Zee, J.; Vanduijn, M.M.; Tijssen, K.; Van Den Broek, P.J.A. 2000: Erythrocytes use intracellular ascorbate as electron donor for the reduction of extracellular ascorbate radicals. Free Radical Biology and Medicine 29(Suppl 1): S96
Wagner, K.F.; Hasegawa, J.; Katschinski, D.M. 2001: Erythrocythemia with a haematocrit of 080 Cardiac dysfunction, reduced exercise performance, and premature death are the consequences of thick blood. European Journal of Anaesthesiology 18(Suppl 21): 50
Crowe, J.H.; Crowe, L.M.; Tablin, F.; Wolkers, W.F.; Tsvetkova, N.M.; Oliver, A.F. 2004: Erythrocytic cells and method for preserving cells. Official Gazette of the United States Patent and Trademark Office Patents 1285(1)
Yoshida, M.; Koshiyama, M.; Fujii, H.; Konishi, M. 1999: Erythrocytosis and a fibroid. Lancet 354(9174): 216
Percy, M.J.; Beard, M.E.J.; Carter, C.; Thein, S.L. 2003: Erythrocytosis and the Chuvash von Hippel-Lindau mutation. British Journal of Haematology 123(2): 371-372
Marie-Cardine, A.; Schneider, P.; Greene, V.; Metayer, J.; Bachy, B.; Vannier, J.P. 2001: Erythrocytosis in a child with a hepatic adenoma. Medical and Pediatric Oncology 36(6): 659-661
Altiparmak, M.R.; Ataman, R.; Ozaras, R.; Tahan, V.; Uzun, H.; Aydin, S.; Serdengecti, K.; Erek, E.; Soysal, T. 2000: Erythrocytosis in patients with renal failure on CAPD. Nephrology Dialysis Transplantation 15(9): A235
Russo, D.; Esposito, R.; Giammarino, A.; Pisani, A.; Carrano, R.; Cirillo, F.; Balletta, M.M.; Federico, S. 2001: Erythrocytosis in renal transplantation Role of ACE gene polymorphism. Nephrology Dialysis Transplantation 16(6): A224
Maruani, A.; Armingaud, P.; Nseir, A.; Luthier, F.; Estève, E. 2003: Erythroderma and multiple cutaneous necrosis revealing a dermatomyositis. Annales de Dermatologie et de Venereologie 130(3): 353-356
Holme, S.A.; Roberts, D.L. 2000: Erythroderma associated with St John's wort. British Journal of Dermatology 143(5): 1127-1128
Rodriguez, B.; De Barrio, M.; Tornero, P.; Herrero, T.; Fuentes, V.; Diaz Jara, M.; Gandolfo, M.; Barranco, R.; Zubeldia, J. 2001: Erythrodermia due to Ribavirin An atopic dermatitis-like eruption. Allergy 56(Suppl 68): 228
Ohshima, A.; Tokura, Y.; Misawa, J.; Yagi, H.; Takigawa, M. 2003: Erythrodermic cutaneous T-cell lymphoma with CD8+CD56+ leukaemic T cells in a young woman. British Journal of Dermatology 149(4): 891-893
Fay, L.; Clark, S.; Harrington, P.; Mulcahy, F.; Bergin, C. 2000: Erythrodysethesia following doxorubicin therapy for Kaposis sarcoma. AIDS 14(Suppl 4): S67
Rincon, J.; Viera, N.; Romero, M.; Mosquera, J. 2001: Erythrogenic toxin type B and its precursor isolated from nephritogenic streptococci increase monocyte chemoattractant protein-1 production by cultured mesangial cells. Nephrology Dialysis Transplantation 16(6): A32
Romero, M.; Rincon, J.; Viera, N.; Mosquera, J. 2001: Erythrogenic toxin type B and its precursor isolated from nephritogenic streptococci increase proliferation and the expression of intercellular adhesion molecule-1 in cultured mesangial cells. Nephrology Dialysis Transplantation 16(6): A31
Lemez, P.; Galikova, J.; Haas, T. 1999: Erythroid and/or megakaryocytic dysplasia in de novo acute myeloid leukemias M0-M5 show their relation to myelodysplastic syndromes. Leukemia Research 23(Suppl 1): S11
Spring, F.A.; Parsons, S.F. 2000: Erythroid cell adhesion molecules. Transfusion Medicine Reviews 14(4): 351-363
Ponnappan, M.; Ponnappan, U.; Udupa, K. 2003: Erythroid cell stimulating factor is essential for normal erythropoiesis. Experimental Hematology (New York) 31(7 Suppl 1): 165-166
Wu, C.J.; Rogers, S.A.; Kutok, J.L.; Hochberg, E.P.; Biernacki, M.; Bridges, K.R.; Antin, J.H.; Ritz, J. 2003: Erythroid chimerism in peripheral blood exceeds bone marrow following non-myeloablative stem cell transplantation in adults with sickle cell anemia. Blood 102(11): 763a
Falcieri, E. 2001: Erythroid differentiation and programmed cell death. FASEB Journal 15(5): A1070
Detmer, K.; Walker, A.N.; Jenkins, T.M.; Steele, T.A.; Dannawi, H. 2000: Erythroid differentiation in vitro is blocked by cyclopamine, an inhibitor of hedgehog signaling. Blood Cells Molecules and Diseases 26(4): 360-372
Papassotiriou, I.; Traeger Synodinos, J.; Kanavakis, E.; Karagiorgia, M.; Stamoulakatou, A.; Kattamis, C. 1999: Erythroid marrow activity and HBH levels in haemoglobinopathy H disease. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S24
Cheever, M.L.; Winkelmann, J.C. 2002: Erythroid-Specific Cleavage of Human beta Spectrin Pre-mRNA. Blood 100(11): Abstract No. 843
Flay, N.W.; Vertel, B.M.; King, D. 2001: Erythroid-specific expression of human growth hormone in marrow stimulates local osteoblast activity. Journal of Bone and Mineral Research 16(Suppl 1): S372
Malik, P. 2002: Erythroid-specific self-inactivating lentiviral vectors express long-term and resist proviral silencing in mice. Blood Cells Molecules and Diseases 28(3): 337-338
Xia, P.; Mohamedali, A.; Puthenveetil, G.; Qureshi, N.; Kuo, I.; Cai, S.; Shah, R.; Malik, P. 2003: Erythroid-specific self-inactivating lentiviral vectors express long-term but do not confer position-independent expression Role of an insulator element. Blood 102(11): 992a
Hohl, D.; Macari, F.; Landau, M.; Cousin, P.; Mevorah, B.; Brenner, S.; Panizzon, R.; Schorderet, D.; Huber, M. 2001: Erythrokeratodermia variabilis is heterogeneous Mutation in the novel connexin 303 gene. Journal of Investigative Dermatology 117(2): 518
Pasquali, F.; Maserati, E.; Panarello, C.; Minelli, A.; Olivieri, C.; Morerio, C.; Bonvini, L.; Russo, I.; Rapella, A.; Rosanda, C.; Danesino, C. 2000: Erythroleukaemia with tetrasomy 21 in a child without down phenotype Evidence for a meiotic origin. European Journal of Human Genetics 8(Suppl 1): 100
Coleman, T.A.; Hamill, R.L.; Ford, S.M. 2001: Erythroleukemia following erythropoietin therapy, extramedullary hematopoiesis, and splenectomy in a patient with myelofibrosis and myeloid metaplasia. American Journal of Hematology 67(3): 214-215
Mork, C.; Asker, C.L.; Salerud, E.G.; Kvernebo, K. 2000: Erythromelalgia A condition with increased arteriovenous shunting. Journal of Vascular Research 37(Suppl 1): 17
Rey, J.; Crétel, E.; Jean, R.; Durand, J.M. 2003: Erythromelalgia in a patient with idiopathic thrombocytopenic purpura. British Journal of Dermatology 148(1): 177
Rudnic, E.M.; Isbister, J.D.; Treacy, D.J.J.; Wassink, S.E. 2003: Erythromyacin antibiotic product, use and formulation thereof. Official Gazette of the United States Patent and Trademark Office Patents 1277(3)
Asaka, T.; Kashimura, M.; Matsuura, A.; Sugimoto, T.; Tanikawa, T.; Ishii, T. 2001: Erythromycin A derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1243(3)
Suh, K.H.; Kim, N.D.; Pae, H.J.; Lee, G.S. 2003: Erythromycin a compounds and process for preparing the same. Official Gazette of the United States Patent and Trademark Office Patents 1268(1)
Asaka, T.; Ishii, T.; Tanikawa, T.; Kashimura, M. 2000: Erythromycin a derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1239(5)
Morimoto, S.; Adachi, T.; Matsunaga, T.; Kashimura, M.; Watanabe, Y.; Sota, K. 2002: Erythromycin a derivatives and method for preparing same. Official Gazette of the United States Patent and Trademark Office Patents 1254(5)
Ohwada, S.; Satoh, Y.; Kawate, S.; Ogawa, T.; Takeyoshi, I.; Koyama, T.; Kawashima, Y.; Kasahara, M.; Yamada, T.; Kawamura, O.; Izumi, M.; Morishita, Y. 2000: Erythromycin accelerates gastric emptying and induces phase III after Billroth I pylorus preserving pancreaticoduodenectomy. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A625
Boivin, M.A.; Carey, M.; Levy, H. 2002: Erythromycin accelerates gastric emptying in a dose-response manner in healthy normals. Journal of Investigative Medicine 50(1): 41A
Davidson, R.J.; Arbique, J.C.; Forward, K.R.; Haldane, D.J. 2000: Erythromycin and clindamycin resistance in pharyngeal isolates of group A Streptococcus in Halifax, Canada. Abstracts of the General Meeting of the American Society for Microbiology 100: 37-38
Bajjoka, I.; Douzdjian, V.; Gottschlich, M.; Amin, N.; Porter, W.; May, E.; Brown, K.A.; Moonka, D.K.; Escobar, F.; Abouljoud, M.S. 1999: Erythromycin breath test as an indicator of tacrolimus safety and efficacy. Hepatology 30(4 Part 2): 186A
Froehlich, S.J.; Mino, D.K.spar, H.; Grasbon, T.; Moehring, C.; Klauss, V.; Kampik, A. 1999: Erythromycin combined with quinolones or aminoglycosides in local treatment of bacterial keratitis. IOVS Investigative Ophthalmology and Visual Science 40(4): S688
Agouridas, C.; Chantot, J.F.; Denis, A.; D'ambrieres, S.G.; Martret, O.L. 2000: Erythromycin compounds. Official Gazette of the United States Patent and Trademark Office Patents 1237(2)
Pellacini, F.; Botta, D.; Romagnano, S.; Albini, E.; Ungheri, D.; Schioppacassi, G. 2003: Erythromycin derivative with antibiotic activity. Official Gazette of the United States Patent and Trademark Office Patents 1271(4)
Wu, Yong Jin 2000: Erythromycin derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1241(3)
Wu, Y.J.; Su, W.G. 2001: Erythromycin derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1248(3)
Wu, Yong Jin 2002: Erythromycin derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1265(4)
Pellacini, F.; Botta, D.; Albini, E.; Ungheri, D. 2002: Erythromycin derivatives with antibiotic activity. Official Gazette of the United States Patent and Trademark Office Patents 1263(4)
Denis, A.; Gigliotti, G. 2002: Erythromycin derivatives, a process for their preparation and their use as medicaments. Official Gazette of the United States Patent and Trademark Office Patents 1261(2)
Agouridas, C.; Chantot, J.F.; Denis, A.; Pejac, J.M. 2000: Erythromycin derivatives, method for preparing same and use thereof as drugs. Official Gazette of the United States Patent and Trademark Office Patents 1241(3)
Ray, C.D.; Lim, D.V. 2000: Erythromycin determinants ErmB and MefA/E in group B Streptococcus. Abstracts of the General Meeting of the American Society for Microbiology 100: 15
Berseth, C.L.; Elhennawy, A. 2002: Erythromycin fails to improve gastrointestinal function or feeding outcome in feeding intolerant preterm infants. Pediatric Research 51(4 Part 2): 143A
Almonte, R.; Patole, S.K.; Kadalraja, R.; Muller, R.; Whitehall, J.S. 1999: Erythromycin for feed intolerance in preterm neonate A randomised, controlled trial. Pediatric Research 45(4 Part 2): 276A
Shiima, Y.; Tsukahara, H.; Kobata, R.; Hayakawa, K.; Hiraoka, M.; Mayumi, M. 2002: Erythromycin in ELBW infants. Journal of Pediatrics 141(2): 297-298
Sanz, M.J.; Naim Abu Nabah, Y.; O'connor, J.E.; Cortijo, J.; Morcillo, E.J. 2003: Erythromycin inhibits LPS-induced leukocyte endothelial cell interactions within the rat mesenteric microvasculature. Methods and Findings in Experimental and Clinical Pharmacology 25(Suppl A): 161
Bassetti, M.; Manno, G.; Collidà, A.; Ferrando, A.; Gatti, G.; Ugolotti, E.; Cruciani, M.; Bassetti, D. 2000: Erythromycin resistance in Streptococcus pyogenes in Italy. Emerging Infectious Diseases 6(2): 180-183
Lofland, D.; Weymouth, L.A. 1999: Erythromycin resistance in viridans streptococci. Abstracts of the General Meeting of the American Society for Microbiology 99: 16
Popivanova, N.I.; Yovtchev, I.P.; Dobreva, M.D.; Argirova, T.A. 2002: Erythromycin resistance of Gram /+/ cocci in Bulgaria Benefits of the new macrolides in the treatment of respiratory infections. International Journal of Antimicrobial Agents 19(Suppl 1): S35
Melgarejo, T.; Simon, D.; Washabau, R.J. 2001: Erythromycin stimulates contractions of canine, but not feline, longitudinal colonic smooth muscle. Journal of Veterinary Internal Medicine 15(3): 313
Posecion, J.E.gar C.; Salari, V.; Ostrea, E.M.Jr 2000: Erythromycin treatment does not decrease incidence of bronchopulmonary dysplasia in very low birth weight infants colonized with Ureaplasma urealyticum. Pediatric Research 47(4 Part 2): 346A
Coudray, S.; Janoly, A.; Belkacem Kahlouli, A.; Bourhis, Y.; Bleyzac, N.; Bourgeois, J.; Putet, G.; Aulagner, G. 2001: Erythromycin-induced digoxin toxiciy in a neonatal intensive care unit. Journal de Pharmacie Clinique 20(2): 129-131
Leadlay, P.F.; Staunton, J.; Cortes, J.; Pacey, M.S. 2001: Erythromycins and process for their preparation. Official Gazette of the United States Patent and Trademark Office Patents 1249(1)
Coyle,D.R.; Aubrey,D.P.; Bentz,J.A. 2010: Erythroneura lawsoni abundance and feeding injury levels are influenced by foliar nutrient status in intensively managed American sycamore. Agricultural And Forest Entomology: 1, 89-97
Mcdaniel, R. 2002: Erythronolide compounds. Official Gazette of the United States Patent and Trademark Office Patents 1259(2)
Macon, W.R.; Przybylski, G.K.; Salhany, K.E.; Choi, J.K.; Kadin, M.E. 1999: Erythrophagocytic T-cell lymphomas are hepatosplenic gammadelta T-cell lymphomas. Modern Pathology 12(1): 142A
Mukhopadhyay, S.; Keating, L.; Souid, A.-K. 2003: Erythrophagocytosis in paroxysmal cold hemoglobinuria. American Journal of Hematology 74(3): 196-197
Garratty, G. 2001: Erythrophagocytosis on the peripheral blood smear and paroxysmal cold hemoglobinuria. Transfusion 41(8): 1073-1074
Grifols, J.; Pujol, M.; Garcia, E.; Salinas, R. 1999: Erythropheresis Optimization, cost and quality of the process. Transfusion 39(10 Suppl): 20S
Varma, S.; Holt, P.J.; Anstey, A.V. 2000: Erythroplasia of queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale. British Journal of Dermatology 142(4): 825-826
Mazzoni, A.; Baicchi, U.; Urciuoli, P.; Bortoli, M.L.; Pardi, C.; Greco, F.; Vanacore, R.; Del Bono, L.; Boldrini, A.; Scatena, F. 1999: Erythroplasmaexchange in malaria treatment. Transfusion 39(10 Suppl): 8S
Juul, S.E.; Ferguson, R.J.; Christensen, R.D. 1999: Erythropoeitin induces differential gene expression in NT2 cells. Pediatric Research 45(4 Part 2): 263A
Siddiqi, S.; Kaplan, B. 2004: Erythropoetic protoporphyria presenting as solar urticaria. Journal of Allergy and Clinical Immunology 113(2 Suppl): S294
Pendharkar, D.; Aousekar, B.V.; Aggarwal, S.; Malhotra, H.; Walia, J. 2002: Erythropoetin in Indian Patients- A Case for Review. Blood 100(11): Abstract No. 3530
Keswani, S.C.; Polley, M.; Leitz, G.J.; Hoke, A. 2003: Erythropoetin is neuroprotective in in vitro models of HIV-associated neuropathy. Journal of Neurovirology 9(Suppl 3): 29
Rafiee, P.; Shi, Y.; Pritchard, K.A.; Baker, J.E. 2004: Erythropoetin protects rabbit heart against subsequent ischemia-reperfusion injury Role of protein kinases. FASEB Journal 18(4-5): Abstract 278
Hillebrand, U.; Matzkies, F.K.; Schaefer, U.; Borrosch, D.; Willich, N.; Micke, O. 2001: Erythropoetin therapy in patients with malignant disease during radiation therapy. International Journal of Radiation Oncology Biology Physics 51(3 Suppl 1): 368
Israels, L.G.; Israels, E.D. 2003: Erythropoiesis An overview. Molineux, Graham , Reprint Author, Foote, M A , Reprint Author, Elliott, S G , Reprint Author Erythropoietins and erythropoiesis: Molecular, Cellular, Preclinical, and Clinical Biology: 3-14
Mohammed, A.K.; Yee, J.; Frinak, S.; Athar, H.; Jasti, J.; Besarab, A.; Osman Malik, Y. 2002: Erythropoiesis and bone healing following parathyroidectomy in hemodialysis patients. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 219A
Mitsopoulos, E.; Ginikopoulou, E.; Giannakou, A.; Kyriklidou, P.; Papadopoulou, D.; Meimaridou, D.; Griveas, I.; Katodrytou, E.; Zanous, S.; Dimas, G.; Papadopoulos, R.; Lagopoulos, B.; Tsiatsou, M.; Pavlitou, A.; Sakellariou, G. 2002: Erythropoiesis and folic acid supplementation in hemodialysis patients. Blood Purification 20(5): 500
Worwood, M.; Carter, K.; Jackson, H.A.; Hutton, R.D.; Cavill, I. 2001: Erythropoiesis and iron status in asymptomatic subjects homozygous for HFE C282Y. British Journal of Haematology 113(Suppl 1): 63
Boening, D.; Rojas, J.; Serrato, M.; Ulloa, C.; Coy, L.; Mora, M.; Gomez, J.; Huetler, M. 2001: Erythropoiesis and physical training in residents of moderate altitude. Pfluegers Archiv European Journal of Physiology 441(6 Suppl): R234
Elliott, S.; Heatherington, A.C.; Foote, M. 2004: Erythropoietic factors Clinical pharmacology and pharmacokinetics. Morstyn, George , Reprint Author, Foote, MaryAnn , Reprint Author, Lieschke, Graham J Hematopoietic growth factors in oncology: Basic science and clinical therapeutics: 97-123
Mathews-Roth, M.M. 2000: Erythropoietic protoporphyria: treatment with antioxidants and potential cure with gene therapy. Methods in Enzymology 319: 479-484
Roels, F.; Bloomer, J.; Risheg, H.; Logan, C.A.; Geraghty, M.T. 2003: Erythropoietic protoporphyria and peroxisomal disorders Polarizing inclusions compared. Journal of Inherited Metabolic Disease 26(Suppl 2): 181
Lang, K.; Fritsch, C.; Lehmann, P.; Ruzicka, T.; Bolsen, K. 2001: Erythropoietic protoporphyria in childhood Early diagnosis in cord blood and in venous blood. Archives of Dermatological Research 293(1-2): 85
Danise, P.; D'arco, A.M.; Amendola, G.; Brugnara, C. 1999: Erythropoietic response to oral and intravenous iron in iron deficiency anemia. Blood 94(10 Suppl 1 Pt 2): 12b-13b
Glaspy, J. 2003: Erythropoietic therapy in the practice of oncology. Molineux, Graham , Reprint Author, Foote, M A , Reprint Author, Elliott, S G , Reprint Author Erythropoietins and erythropoiesis: Molecular, Cellular, Preclinical, and Clinical Biology: 163-184
Danielyan, L.; Kuci, S.; Harsch, S.; Schneider, C.; Wiesinger, H.; Weller, M.; Diekmann, J.; Wessels, J.; Buniatian, G.; Gleiter, C.H. 2003: Erythropoietin -induced proliferation of human and rat astrocytes under normoxic and hypoxic conditions. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R120
Monga, D.K.; Tan, X.; Sneddon, T.; Koehler, C.; Michalopoulos, G.; Monga, S.P.l S. 2003: Erythropoietin A potent negative regulator of beta-catenin in hepatocytes and liver cancer cells. Proceedings of the American Association for Cancer Research 44: 467
Heyman, S.N.; Rosenberger, C.; Rosen, S. 2004: Erythropoietin: a potential remedy for renal tubular injury?. Kidney International 65(2): 737-738
Mittelman, M. 2001: Erythropoietin Basic aspects-structure, regulation, mechanism of action and biological effects. Leukemia Research 25(Suppl 1): S7
Chong, Z.Z.; Kang, J.-Q.; Maiese, K. 2003: Erythropoietin: cytoprotection in vascular and neuronal cells. Current Drug Targets. Cardiovascular and Haematological Disorders 3(2): 141-154
Sytkowski, A.J.; Grodberg, J. 2000: Erythropoietin DNA having modified 5 and 3 sequences and its use to prepare EPO therapeutics. Official Gazette of the United States Patent and Trademark Office Patents 1240(4)
Raja, K.B.; Sandhu, K.; Laftah, A.; Maxwell, P.H.; Ratcliffe, P.J.; Simpson, R.J.; Peters, T.J. 2000: Erythropoietin Effects on haem biosynthesis. Clinical Science 98(2): 10P
Sigounas, G.; Collins, M.; Sallah, S.; Sigounas, V. 2002: Erythropoietin Enhances Antineoplastic Activity of Chemotherapeutic Agents. Blood 100(11): Abstract No. 4350
Mittelman, M.; Zeidman, A.; Fradin, Z.; Kanter, P.; Katz, O.; Neumann, D. 2002: Erythropoietin Has an Anti-Myeloma Effect - A Clinical Observation Supported by Animal Studies. Blood 100(11): Abstract No. 5127
Chu, X.; Cheung, J.Y.; Tong, Q.; Barber, D.L.; Conrad, K.; Abrasonis, V.; Zhang, W.; Birnbaumer, L.; Miller, B.A. 2002: Erythropoietin Modulation of Calcium Influx through TRPC in Primary Splenic Erythroblasts. Blood 100(11): Abstract No. 2035
Arcasoy, M.O.; Karayal, A.F. 2002: Erythropoietin Receptor Cytoplasmic Domain Tyrosine Residues TYR-285 and TYR-344 Are Required for EPO Hypersensitivity Associated with EPO Receptor Mutation and Primary Familial Polycythemia. Blood 100(11): Abstract No. 150
Arcasoy, M.O.; Amin, K.; Haroon, Z.A. 2002: Erythropoietin Receptor Expression in Macrophages Is Associated with EPO-Mediated Stimulation of Wound Healing Response, Angiogenesis and Transforming Growth Factor beta-1 Production. Blood 100(11): Abstract No. 2685
Katz, O.; Barzilay, E.; Herman, A.; Kanter, P.; Neumann, D.; Mittelman, M. 2002: Erythropoietin Reduces Tumor Load in a MOPC-315 Myeloma Mouse Model. Blood 100(11): Abstract No. 5092
Hamadmad, S.N.; Henry, M.K.; Hohl, R.J. 2004: Erythropoietin Signal Transduction Requires Protein Geranylgeranylation. FASEB Journal 18(4-5): Abstract 168
Beleslin Cokic, B.B.; Cokic, V.P.; Yu, X.; Weksler, B.B.; Schechter, A.N.; Noguchi, C.T. 2002: Erythropoietin Stimulates a Nitric Oxide Response in Vascular Endothelial Cells. Blood 100(11): Abstract No. 3760
Haliko, S.; Li, H.; Garcia, C.; Webster, K.A. 2003: Erythropoietin activates PI3-kinase and Akt in neonatal cardiac myocytes and protects against apoptosis caused by hypoxia-reoxygenation but not hypoxia-acidosis. Circulation 108(17): IV114
Lipsic, E.; Van Der Meer, P.; De Boer, R.A.; Suurmeijer, A.J.H.; Van Gilst, W.H.; Van Veldhuisen, D.J.; Henning, R.H. 2004: Erythropoietin activates map kinase in isolated rat hearts. Naunyn-Schmiedeberg's Archives of Pharmacology 369(Suppl 1): R170
Soin, R.; Lockhart, A.; Cozzi, E.; Scott, M.; Rushworth, S.; White, D.J.; Friend, P.J.; Bradley, J.R. 2001: Erythropoietin activity between species A model for hormonal compatibility in xenotransplantation. Xenotransplantation 8(Suppl 1): 131
Allegra, A.; Buemi, M.; Corica, F.; Aloisi, C.; Frisina, N. 1999: Erythropoietin administration induces an increase of serum levels of soluble E-selectin and soluble intercellular adhesion molecule 1. Nephron 82(4): 361-362
Rigourd, V.; Kieffer, F.; Dommergues, M.A.; Ayachi, A.; Assaf, Z.; Mohamed, I.; Voyer, M.; Magny, J.F. 2004: Erythropoietin administration to preterm infants: comparison between subcutaneous and intravenous route. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 11(4): 319-326
Carluccio, F.; Siems, W.; Valderrabano, F.; Luno, J. 2002: Erythropoietin administration, hemoglobin values and oxidative stress in thalassaemic patients on chronic hemodialysis. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 132
Malyszko, J.; Suchowierska, E.; Malyszko, J.S.; Mysliwiec, M. 2001: Erythropoietin affects hemostasis in CAPD patients. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 433A
Sigounas, G.; Mehlhop, P.; Sigounas, A.; Collins, M.; Li, W. 2001: Erythropoietin ameliorates chemotherapy-induced toxicity in vivo. Experimental Hematology 29(8 Suppl 1): 57
Young, M.; Meade, H.; Krane, I. 2003: Erythropoietin analog-human serum albumin fusion. Official Gazette of the United States Patent and Trademark Office Patents 1269(3)
Suzuki, K.; Hayashi, T.; Kato, T.; Ishida, Y.; Inoue, H. 2002: Erythropoietin and Thrombopoietin Affect Expression of Plasminogen Activator Inhibitor-1 and Tissue Factor Pathway Inhibitor mRNA in Human Umbilical Endothelial Cells. Blood 100(11): Abstract No. 3773
Batra, S.; Perelman, N.; Luck, L.; Reynolds, P.; Shimada, H.; Malik, P. 2002: Erythropoietin and erythropoietin receptor are expressed in common pediatric cancer cells and promote release of vascular endothelial growth factor. Proceedings of the American Association for Cancer Research 43: 895
Haroon, Z.A.; Amin, K.; Karayal, A.F.; Arcasoy, M.O. 2002: Erythropoietin and erythropoietin receptor blockage reduces tumor growth and angiogenesis in vivo. Proceedings of the American Association for Cancer Research 43: 177-178
Van, D.L.osdrecht, A.A.; Ossenkoppele, G.J. 2003: Erythropoietin and granulocyte colony-stimulating factor in low-risk myelodysplasia Impact on apoptosis of hematopoietic progenitors. Leukemia 17(3): 664
Totsune, K.; Takahashi, K.; Mackenzie, H.S.; Murakami, O.; Arihara, Z.; Sone, M.; Satoh, F.; Brenner, B.M.; Ito, S. 2000: Erythropoietin and heme oxygenase-1 mRNA levels are increased in the rat remnant kidney following 5/6 renal mass ablation. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 429A
Lipton, S.A.; Kaul, M.; Fletcher, L.; Digicaylioglu, M. 2003: Erythropoietin and insulin-like growth factor-I protect neurons from HIV/gp120-induced damage. Neurology 60(5 Suppl 1): A248
Kessler, U.; Gottschaik, R.; Moeller, B.; Stucki, G.; Kaltwasser, J.P.ter 1999: Erythropoietin and intravenous iron A new combination for patients with rheumatoid arthritis and anaemia of chronic disease. Arthritis and Rheumatism 42(9 Suppl): S239
Ford, P.; Niederer, K.; Ku, R.; Keck, G.; Henry, D. 2003: Erythropoietin and intravenous iron priming in preoperative gynecological patients. Blood 102(11): 15b
Murrone, P.; Balducci, A. 1999: Erythropoietin and iron-gluconate combined therapy in dialysed patients. Nephrology Dialysis Transplantation 14(9): A258
Kaltwasser, J.P. 2001: Erythropoietin and iv iron in patients with anemia of chronic disease. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S43
Leyland-Jones, B.; O'shaughnessy, J.A. 2003: Erythropoietin as a critical component of breast cancer therapy: survival, synergistic, and cognitive applications. Seminars in Oncology 30(5 Suppl 16: 174-184
Grasso, G.; Sfacteria, A.; Cerami, A.; Brines, M. 2004: Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go?. Neuroscientist: a Review Journal Bringing Neurobiology Neurology and Psychiatry 10(2): 93-98
Nakamatsu, K.; Suzuki, M.; Kanamori, S.; Nishimura, Y.; Yasuda, Y. 2001: Erythropoietin as an angiogenic factor in murine hepatic tumors. European Journal of Cancer 37(Suppl 6): S112
Ehrenreich, H.; Siren, A.L. 2001: Erythropoietin as an approach for neuroprotection From cellular mechanisms of action to application in human stroke. Journal of Neurochemistry 78(Suppl 1): 74
Kozlov, V.; Injelevskaya, T.; Krysov, S.; Sennikov, S. 2002: Erythropoietin as modulator of cytokine-synthesizing activity of erythroid cells. Experimental Hematology (Charlottesville) 30(6 Suppl 1): 63
Parsa, C.J.; Matsumoto, A.; Walton, G.B.; Stamler, J.S.; Koch, W.J. 2003: Erythropoietin augments cardiomyocyte survival and left ventricular function after hypoxia. Journal of the American College of Cardiology 41(6 Suppl A): 399A
Hershkovitz, R.; Ohel, I.; Sheizaf, B.; Nathan, I.; Sheiner, E.; Erez, O.; Mazor, M. 2003: Erythropoietin concentration among patients with preeclampsia. American Journal of Obstetrics and Gynecology 189(6 Suppl): S192
Burg, J.; Hilger, B.; Josel, H.P.ter 2002: Erythropoietin conjugates. Official Gazette of the United States Patent and Trademark Office Patents 1254(4)
Bosman, D.R.; Winkler, A.S.; Marsden, J.; Watkins, P.J. 1999: Erythropoietin deficient anaemia of early diabetic nephropathy. Diabetologia 42(Suppl 1): A278
Mayaudon, H.; Dupuy, O.; Belmejdoub, G.; Bordier, L.; Garcin, J.; Bauduceau, B. 2002: Erythropoietin depletion and cardiac autonomic neuropathy in type 1 diabetes. Diabetologia 45(Suppl 2): A 327
Nelson, A.; Howe, C.; Nguyen, T.; Leung, K.; Trout, G.; Seibel, M.; Baxter, R.; Handelsman, D.; Kazlauskas, R.; Irie, M.; Ho, K. 2004: Erythropoietin does not modulate the growth hormone/IGF axis in recreational athletes. Growth Hormone and IGF Research 14(2): 136
Jacobs, A.A.; Gaweda, A.E.; Brier, M.E. 2003: Erythropoietin dosing in hemodialysis patients using intelligent modeling and control. Journal of the American Society of Nephrology 14(Abstracts Issue): 458A-459A
Lee, M.S.; Lee, J.S.; Lee, J.Y.; Halberg, F. 2002: Erythropoietin effects on blood pressure, hematocrit and body weight. American Journal of Hypertension 15(4 Part 2): 128A-129A
Mcpherson, R.J.; Miller, S.; Juul, S.E. 2003: Erythropoietin enhances cell division and migration in the small intestine of neonatal rats. Pediatric Research 53(4 Part 2): 387A
Ommani, A.W.; Cheung, D.; Walker, B.R.; Kanagy, N.L. 2000: Erythropoietin enhances nitric oxide dependent relaxation of rat aorta and upregulates endothelial nitric oxide synthase. FASEB Journal 14(4): A410
Antonadou, D.; Cardamakis, E.; Puglisi, M.; Malamos, N.; Throuvalas, N. 2001: Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies Final results of a randomized phase III study. European Journal of Cancer 37(Suppl 6): S144
Kirschner, K.; Porzig, H.; Baltensperger, K. 2003: Erythropoietin enhances the development of resistance in imatinib treated K562 cells. Experimental Hematology (New York) 31(7 Suppl 1): 229-230
Westenfelder, C.; Baranowski, R.L. 2001: Erythropoietin exerts an anti-apoptotic effect in normal human proximal tubular cells but not in kidney cancer cells that lack the von Hippel-Lindau tumor suppressor gene. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 623A
Dev, A.; Patel, K.; Muir, A.; McHutchison, J.G. 2003: Erythropoietin for ribavirin-induced anemia in hepatitis C: more answers but many more questions. American Journal of Gastroenterology 98(11): 2344-2347
Boussinesq, M.; Kamgno, J.; Pion, Sébastien.D.; Mackenzie, C.D. 2010: Erythropoietin for treating post-ivermectin Loa-related serious adverse events?. Trends in Parasitology 26(1): 4-5
Garcia Del Barco, D.; Rodriguez, A.; Rodriguez, E.; Tamayo, C.; Fernandez, J.R.; Vasquez, M.M.; Rodriguez, M.P.; Lleonart, R. 1999: Erythropoietin gene co-amplification in methotrexate-resistant Chinese hamster ovary dhfr- cells. Biotecnologia Aplicada 16(4): 232-235
Dobashi, M.; Fujisawa, M.; Maruyama, H.; Goda, K.; Okada, H.; Kamidono, S. 2003: Erythropoietin gene expression and their association with spermatogenesis in rat testis using in vivo electroporation. Journal of Urology 169(4 Suppl): 414
Wiesener, M.S.; Glaeser, M.; Warnecke, C.; Frei, U.A.; Groene, H.J.; Eckardt, K.U. 2002: Erythropoietin gene expression is upregulated in only a subset of HIF alpha positive clear cell renal carcinoma. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 197
Wiesener, M.S.; Glaser, M.; Warnecke, C.; Frei, U.A.; Grone, H.J.; Eckardt, K.U. 2001: Erythropoietin gene expression is upregulated in only a subset of HIFalpha clear cell renal cancer. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 623A
Wiesener, M.S.; Glaeser, M.; Warnecke, C.; Frei, U.A.; Groene, H.J.; Eckardt, K.U. 2001: Erythropoietin gene expression is upregulated in only a subset of HIFalpha positive clear cell renal cancer. Kidney and Blood Pressure Research 24(4-6): 368
Buemi, M.; Galeano, M.R.; Sturiale, A.; Sansotta, C.; Vaccaro, M.; Squadrito, F.; Calapai, G.; Montalto, G.; Giacobbe, M.S.; Frisina, N. 2000: Erythropoietin has a neoangiogenetic effect in a rat model of ischemic injury. Nephrology Dialysis Transplantation 15(9): A33
Mancini, D.; Katz, S.; Lamanca, J.; Hryniewicz, K.; Hudaihed, A.; Lejemtel, T.H.; Androne, A.S.; Dimayuga, C. 2001: Erythropoietin improves exercise capacity in patients with heart failure. Circulation 104(17): 2; 438
Horsman, M.R.; Finch, A.; Overgaard, J. 2003: Erythropoietin improves the oxygen carrying capacity of mouse blood without changing hypoxia in a murine tumour model. EJC Suppls 1(5): S13
Jonas, S.; Wild, C. 2000: Erythropoietin in cancer related anemia An assessment. Onkologie 23(Sonderheft 7): 172
Grossi, A.; Musto, P.; Santini, V.; Balestri, F.; Scazulli, R.; D'arena, G.; Rossiferrini, P.; Carotenuto, M. 2001: Erythropoietin in combination with amifostine in the treatment of myelodysplastic syndromes. Leukemia Research 25(Suppl 1): S71
Gessoni, G.; Zussa, C.; Polesel, E.; Arreghini, N.; Fezzi, I.; De Fusco, G.; Marchiori, G. 2000: Erythropoietin in intensive autologous blood donation schedule Study of reticulocyte indexes. Vox Sanguinis 78(Suppl 1): P272
Acarregui, M.J.; Richman, J.T.; Littig, J.L. 2003: Erythropoietin increases SP-A protein levels and capillary endothelial cell proliferation in human fetal lung in vitro. Pediatric Research 53(4 Part 2): 35A-36A
Pinel, S.; Chastagner, P.; Moyal, E.C.hen Jonathan; Barberi Heyob, M.; Merlin, J.L.uis 2003: Erythropoietin induced-high hemoglobin levels reduce hypoxia and improve tumor tissue response to ionizing radiation in human glioma xenografts. Proceedings of the American Association for Cancer Research 44: 885-886
Resch, B.; Falkay, G.; Letoha, A.; Sonkodi, S. 2001: Erythropoietin induces vasoconstriction in rat mesenteric and human blood vessels. Nephrology Dialysis Transplantation 16(6): A8
Fodinger, M.; Fritsche Polanz, R.; Buchmayer, H.; Skoupy, S.; Horl, W.H.; Sunder Plassmann, G. 1999: Erythropoietin inducible immediate-early genes in human vascular endothelial cells. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 395A-396A
Pietrzak, I.P.; Bladek, K.M.; Baczyk, K.M. 2000: Erythropoietin influences the pentose-phosphate shunt and lipoperoxidation in ESRD patients. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 294A
Martin Malo, A.; Ramirez, R.; Carracedo, J.; Soriano, S.; Aljama, P. 2003: Erythropoietin inhibits apoptosis of endothelial cells induced by uremia and hemodialysis. Journal of the American Society of Nephrology 14(Abstracts Issue): 536A
Sigounas, G.; Salleng, K.J.; Collins, M.C.; Sigounas, D.G. 2003: Erythropoietin inhibits endothelial cell activation and intercellular adhesion molecule-1 expression. Experimental Hematology (New York) 31(7 Suppl 1): 79-80
Westenfelder, C.; Baranowski, R.L.; Sullivan, C. 1999: Erythropoietin is a renotropic cytokine Significance in the biology of normal and malignant renal tubular cells. Journal of Investigative Medicine 47(2): 1A
Toegel, F.; Joseph, A.J.; Hu, Z.; Baranowski, R.L.; Loghman Adham, M.; Westenfelder, C. 2002: Erythropoietin is a renotropic cytokine with anti-apoptotic, chemokinesis-stimulating, motogenic and mitogenic actions Significance in acute renal failure , renal cancer and polycystic kidney disease. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 93A-94A
Watson, W.P. 2002: Erythropoietin is anticonvulsant against kainic acid-induced seizures, but not pilocarpine, pentylenetetrazol, or electroshock seizures. Epilepsia 43(Suppl 7): 103
Strickland, T.W. 1999: Erythropoietin isoforms. Official Gazette of the United States Patent and Trademark Office Patents 1218(1): 401
Mayaudon, H.; Carmoi, T.; Margery, J.; Ficko, C.; Burnat, P.; Bordier, L.; Dupuy, O.; Bauduceau, B. 2003: Erythropoietin level and diabetic nephropathy. Diabetes and Metabolism 29(Hors serie 2): 4S300
Naeff, R.; Delmenico, S.; Wetter, A.; Floether, F.U.rich 2003: Erythropoietin liposomal dispersion. Official Gazette of the United States Patent and Trademark Office Patents 1276(2)
Senkbeil, L.E.; Moss, J.G.; Gaglio, P.J.; Dove, L.M.; Lobritto, S.J.; Jacobson, I.M.; Brown, R.S.J. 2003: Erythropoietin maintains ribavirin dose and sustained virologic response during HCV treatment. Hepatology 38(4 Suppl 1): 744A
Monga, S.P.l S.; Koehler, C.; Pediaditakis, P.; Bowen, W.C.; Michalopoulos, G.K. 2002: Erythropoietin modulates Wnt pathway by beta-Catenin stabilization in the primary hepatocyte cultures. Proceedings of the American Association for Cancer Research 43: 1050
Baig, S.; Patel, Y.; Coussons, P.J.; Grant, R. 2002: Erythropoietin modulates interleukin-1 beta induced nitrite production in rheumatoid synovial fibroblasts. Biochemical Society Transactions 30(5): A105
Milutinovic, S.; Krpan, D.; Drenovac, M. 2002: Erythropoietin omega improves cognitive functioning and quality of life in dialysis patients in comparison to alfa. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 718A
Zelman, G.; Howland, M.A.; Nelson, L.S.; Hoffman, R.S. 1999: Erythropoietin overdose treated with emergent erythropheresis. Journal of Toxicology. Clinical Toxicology 37(5): 602-603
Tacke, F.; Schoffski, P.; Ganser, A.; Manns, M.P.; Trautwein, C. 2002: Erythropoietin plasma levels are elevated in chronic liver disease and correlate with anemia, liver dysfunction, bleeding episodes and interleukin-6. Journal of Hepatology 36(Suppl 1): 65
Balestra, C.; Germonpré, P.; Poortmans, J.; Marroni, A.; Schiettecatte, J.; Collard, J.F.; Snoeck, T. 2004: Erythropoietin production can be enhanced by normobaric oxygen breathing in healthy humans. Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 31(1): 53-57
Baranowski, R.L.; Westenfelder, C. 2001: Erythropoietin promotes survival of growth factor deprived and injured neuronal cells by modulation of caspase activity Significance in uremic encephalopathy. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 606A
Baranowski, R.L.; Westenfelder, C. 2000: Erythropoietin promotes survival of hydrogen peroxide-injured neuronal cells. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 450A
Rui, T.; Cepinskas, G.; Kvietys, P.R. 2003: Erythropoietin protects against anoxia/reoxygenation-induced development of a proinflammatory phenotype in cardiac myocytes. FASEB Journal 17(4-5): Abstract 668
Lipsic, E.; Van Der Meer, P.; Suurmeijer, A.J.H.; Schoemaker, R.G.; Van Veldhuisen, D.J.; Van Gilst, W.H.; Henning, R.H. 2003: Erythropoietin protects against ischaemic damage in isolated rat heart. European Heart Journal 24(Abstract Suppl): 477
Diglcaylioglu, M.; Lipton, S.A. 1999: Erythropoietin protects against nitric oxide -induced neuronal apoptosis via a JAK-2/NF-kappaB signaling pathway. Society for Neuroscience Abstracts 25(1-2): 1088
Rui, T.; Cepinskas, G.; Kvietys, P.R. 2004: Erythropoietin protects cardiac myocytes from the dysfunction and injury induced by simulated ischemia/reperfusion role of transcription factor AP-1. FASEB Journal 18(4-5): Abstract 170
Keswani, S.; Polley, M.; Hoke, A. 2003: Erythropoietin protects dorsal root ganglion neurons against gp120 and ddC-induced neurotoxicity. Annals of Neurology 54(Suppl 7): S77
Kirschner, K.M.; Porzig, H.; Baltensperger, K. 2003: Erythropoietin protects the CML cell line K562 from imatinib induced apoptosis. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R59
Van Der Meer, Peter; Lipsic, Erik; Henning, Rob H.; De Boer, Rudolf A.; Suurmeijer, Albert J.; Van Veldhuisen, Dirk J.; Van Gilst, Wiek H. 2003: Erythropoietin protects the heart against ischemia-reperfusion injury. Circulation 108(17): IV187-IV188
Sharples, E.J.; Patel, N.; Brown, P.; Stewart, K.; Mota Philipe, H.; Sheaff, M.; Allen, D.A.; Harwood, S.M.; Kieszkiewicz, J.; Raftery, M.J.; Thiemermann, C.; Yaqoob, M.M. 2003: Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion injury by the inhibition of the caspase cascade and apoptosis. Journal of the American Society of Nephrology 14(Abstracts Issue): 273A
Boahene, D.O.; Adunyah, S.E. 1999: Erythropoietin rapidly induces activation of serine/threonine kinases and phosphatases in human k563 erythroleukemia cells. Proceedings of the American Association for Cancer Research 40: 717
Lodish, H.F. 2000: Erythropoietin receptor Signals and pathways. Acta Haematologica (Basel) 103(Suppl 1): 98
Young, P.R.; Erickson Miller, C.L. 2000: Erythropoietin receptor antibodies. Official Gazette of the United States Patent and Trademark Office Patents 1240(4)
Petersen, K.B.; Hokland, P.; Petersen, G.B.; Nyvold, C.G.; Brorson Petersen, K.; Bruun Petersen, G.; Guldborg Nyvold, C. 2004: Erythropoietin receptor defect: a cause of primary polycythaemia. British Journal of Haematology 125(4): 537-538
Shenouda, G.; Belenkov, A.; Souhami, L.; Duclos, M.; Portelance, L.; Chow, T. 2003: Erythropoietin receptor expression and the in-vitro effect of erythropoietin on the radiation-response of different cancer cell lines. EJC Suppls 1(5): S147
Haroon, Z.A.; Zhou, S.; He, C.; Jiang, X.; Arcasoy, M.O. 2003: Erythropoietin receptor expression in non-small cell lung cancer. FASEB Journal 17(4-5): Abstract 161
Stewart, J.P.; Maxwell, P.; Lappin, T.R.J. 2003: Erythropoietin receptor expression is modulated by hypoxia in multiple myeloma cell lines. British Journal of Haematology 121(Suppl 1): 10-11
Widness, J.A.; Lambert, D.J.; Schmidt, R.L.; Schutte, B.C. 1999: Erythropoietin receptor gene expression in humans is greater in the fetus compared to the adult. Pediatric Research 45(4 Part 2): 265A
Poveshchenko, A.; Abramov, V.; Korotkova, N.; Yakushenko, E.; Kozlov, V. 1999: Erythropoietin receptor mRNA is expressed in the brain hemispheres of F1 mice. Neuroimmunomodulation 6(6): 436
Takahashi, M.; Kawakami, M.; Sekiguchi, M.; Sato, K. 2001: Erythropoietin receptor mediated inhibition of exocytotic glutamate release and suppression of ischemic neuronal cell death in hippocampal slices. Japanese Journal of Pharmacology 85(Suppl 1): 55P
Ghaffari, S.; Huang, L.J.n Shen; Zhang, J.; Lodish, H.F. 2003: Erythropoietin receptor signaling processes. Molineux, Graham , Reprint Author, Foote, M A , Reprint Author, Elliott, S G , Reprint Author Erythropoietins and erythropoiesis: Molecular, Cellular, Preclinical, and Clinical Biology: 65-85
Kahlert, S.; Bauerfeind, I.; Ditsch, N.; Untch, M. 2003: Erythropoietin reduces chemotherapy-induced anemia during adjuvant dose-intensified, short-duration Epirubicin and Cyclophosphamide therapy for node positive breast cancer patients. Breast Cancer Research and Treatment 82(Suppl 1): S155
Bahlmann, Ferdinand H.; De Groot, Kirsten; Boehm, Sascha; Duckert, Thorsten; Kielstein, Jan T.; Haller, Hermann; Fliser, Danilo 2003: Erythropoietin regulates endothelial progenitor cells in vitro. Journal of the American Society of Nephrology 14(Abstracts Issue): 335A
De Groot, Kirsten; Bahlmann, Ferdinand H.; Duckert, Thorsten; Boehm, Sascha M.; Jan, Kielstein T.; Haller, Hermann; Fliser, Danilo 2003: Erythropoietin regulates endothelial progenitor cells in vivo. Circulation 108(17): IV222
Movilli, E.; Cancarini, G.C.; Vizzardi, V.; Camerini, C.; Brunori, G.; Pertica, N.; Maiorca, R. 2002: Erythropoietin requirement does not depend on dialysis dose when Kt/V12 in patients on dialysis with cellulosic membranes and adequate iron stores. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 726A
Movilli, E.; Cancarini, G.C.; Vizzardi, V.; Camerini, C.; Brunori, G.; Pertica, N.; Cassamali, S.; Maiorca, R. 2002: Erythropoietin requirement is independent on dialysis dose when Kt/Vgtoreq12. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 135
Yaqub, M.S.; Leiser, J.; Molitoris, B.A. 2000: Erythropoietin requirements increase following hospitalization in hemodialysis patients. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 253A-254A
Kirschbaum, B. 1999: Erythropoietin requirements of hemodialysis patients. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 288A
Pennell, P.; Augustine, B.A.; Rojas, C.; Walters, B.A.J. 2000: Erythropoietin resistance in dialysis patients after renal transplant rejection. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 294A
Dulau, I.A.; Popescu, G.; Roman, V.; Hosu, I. 2000: Erythropoietin resistance in patients on maintenance hemodialysis. Nephrology Dialysis Transplantation 15(9): A162
Semba, R.D.; Broadhead, R.; Taha, T.E.; Totin, D.; Ricks, M.O.; Kumwenda, N. 2001: Erythropoietin response to anemia among human immunodeficiency virus-infected infants in Malawi. Haematologica 86(11): 1221-1222
Mbuya, N.V.; Malaba, L.C.; Miller, M.; Stoltzfus, R.J.; Rasmussen, K.M.; Humphrey, J.H. 2004: Erythropoietin response to anemia is not impaired by HIV infection among Zimbabwean lactating women during the immediate postpartum period. FASEB Journal 18(4-5): Abstract 358
Pronai, W.; Silberbauer, K. 1999: Erythropoietin response to folic acid substitution. Nephron 81(3): 353
Lang, P.A.; Birka, C.; Myssina, S.; Lang, K.S.; Duranton, C.; Vallon, V.; Wieder, T.; Lang, F.; Huber, S.M. 2003: Erythropoietin sensitive cation channels in the regulation of erythrocyte apoptosis. Journal of the American Society of Nephrology 14(Abstracts Issue): 95A
Acs, G.; Zhang, P.J.; Mohyeldin, A.; Liu, S.; Lu, H.; Mcbroom, J.; Verma, A. 2003: Erythropoietin signaling in cervical carcinoma A pathway of hypoxia-mediated treatment resistance. Modern Pathology 16(1): 178A
Yamazaki, T.; Morita, T.; Nagai, H. 2000: Erythropoietin solution preparation. Official Gazette of the United States Patent and Trademark Office Patents 1238(3)
Arcasoy, M.O.; Amin, K.; Haroon, Z.A. 2001: Erythropoietin stimulates angiogenesis in vivo and promotes wound healing. Blood 98(11 Part 1): 822a-823a
Tennant, J.; Anderson, E.; Sharp, P. 2002: Erythropoietin stimulates iron uptake across the apical membrane of human intestinal Caco-2 cells. Journal of Physiology (Cambridge) 539P: 21P
Westenfelder, C.; Baranowski, R.L. 1999: Erythropoietin stimulates mitogenesis in a cell line of human renal cell carcinoma that lacks the von Hipple-Lindau tumor suppressor gene Potential clinical significance. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 186A
Sohn, N.W.; Kim, H.H.; Lim, J.Y.; Chae, H.J.; Kim, K.E.; Shin, J.W.; Jung, H.S. 2004: Erythropoietin stimulates neurogenesis in adult rat brain and organotypic hippocampal slice cultures. FASEB Journal 18(4-5): Abstract 311
Noguchi, C.T.; Yu, X.; Rogers, H.; Beleslin Cokic, B.; Epstein, R. 2002: Erythropoietin stimulation of differentiating progenitor cells Not for red cells only. Blood Cells Molecules and Diseases 28(3): 340
Richardson, R.M.; Cheung, W.K.; Marra, L.E.; Jamal, N.; Messner, H.A. 2003: Erythropoietin stimulation of human BFU-E in vitro. Journal of the American Society of Nephrology 14(Abstracts Issue): 884A
Beleslin Cokic, B.B.; Gojkovic Bukarica, L.; Cokic, V.P.; Noguchi, C.T. 2003: Erythropoietin stimulation of isolated human blood vessels and vascular smooth muscle cells. Blood 102(11): 533a
Gomes, F.R.; Marques, A.; Costa, O. 2001: Erythropoietin therapy Is there a place in advanced prostate cancer-related anemia?. European Journal of Cancer 37(Suppl 6): S222
Pisoni, R.L.; Young, E.W.; Gillespie, B.W.; Locatelli, F.; Combe, C.; Akiba, T.; Akizawa, T.; Wolfe, R.A.; Held, P.J.; Port, F.K. 2003: Erythropoietin therapy and associated hemodialysis patient characteristics DOPPS results. Journal of the American Society of Nephrology 14(Abstracts Issue): 267A
Santoro, A. 2002: Erythropoietin therapy and the cardiovascular system. Contributions to Nephrology 137: 431-435
Lund, G.; Ratner, I.; Lee, S.K.; Zupancic, J.A.F.; Raina, P.; Lisonkova, S. 2001: Erythropoietin therapy decreases blood transfusion in the NICU. Pediatric Research 49(4 Part 2): 405A
Pisoni, R.L. 2002: Erythropoietin therapy in Europe: results from the DOPPS. Contributions to Nephrology 137: 396-402
Trivedi, H.S.; Brooks, B.J. 2003: Erythropoietin therapy in pre-dialysis patients with chronic renal failure: lack of need for parenteral iron. American Journal of Nephrology 23(2): 78-85
Collins, A.; Li, S.Y.; St Peter, W.L.; Ebben, J.; Ma, J.Z. 2000: Erythropoietin therapy with inadequate intravenous iron dosing is less likely to increase low hematocrit levels. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 262A
Ohls, R.K. 1999: Erythropoietin to prevent and treat the anemia of prematurity. Current Opinion in Pediatrics 11(2): 108-114
Westenfelder, C.; Baranowski, R.L. 2001: Erythropoietin treatment ameliorates ischemic acute renal failure in rats by its anti-apoptotic, motogenic and mitogenic actions. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 739A
Aulakh, P.; Malik, P.; Siassi, B.; Sardesai, S.R.; Ramanathan, R. 2002: Erythropoietin treatment and gtoreq stage III retinopathy of prematurity in very low birth weight infants. Journal of Investigative Medicine 50(1): 43A
Ursea, N.; Garneata, L.; Capusa, C. 1999: Erythropoietin treatment and lipid metabolism in hemodialyzed patients. Nephrology Dialysis Transplantation 14(9): A255
Wallvik, J.; Stenke, L.; Bernell, P.; Nordahl, G.; Hippe, E.; Hast, R. 2001: Erythropoietin treatment in MDS anaemia-serum EPO a predictor for response and survival. Leukemia Research 25(Suppl 1): S73-S74
Birgegard, G. 2001: Erythropoietin treatment in cancer anaemia. Leukemia Research 25(Suppl 1): S7-S8
Ohls, R.K. 2002: Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out. Journal of Pediatrics 141(1): 3-6
Acchiardo, S.R.; Wang, Y.; Cardenas, R.; Tevlin, M.T.; Mishra, S.; Kang, E.S. 1999: Erythropoietin treatment may be associated with increased NO2+NO3 generation and hypotension during hemodialysis. Journal of Investigative Medicine 47(2): 145A
Solar, P.; Feldman, L.; Sytkowski, A.J. 2003: Erythropoietin treatment of ovarian carcinoma cells results in a paclitaxel-resistant phenotype. Blood 102(11): 206b
Walton, T.; Macon, E.J. 2002: Erythropoietin use in a Jehovah's Witness patient. Annals of PharmacoTherapy 36(4): 729-730
Fox, C.P.; Pacey, S.; Das Gupta, E.; Russell, N.; Byrne, J. 2004: Erythropoietin used early after allogeneic transplantation is effective at reducing anaemia and the need for blood transfusions. British Journal of Haematology 125(Suppl 1): 3
Trial, J.; Rice, L. 2004: Erythropoietin withdrawal leads to the destruction of young red cells at the endothelial-macrophage interface. Current Pharmaceutical Design 10(2): 183-190
Ballin, A.; Bilker-Reich, A.; Arbel, E.; Davidovitz, Y.; Kohelet, D. 1999: Erythropoietin, given enterally, stimulates erythropoiesis in premature infants. Lancet 353(9167): 1849
Ionova, D.; Sepetlieva, K.; Tcachev, K. 2000: Erythropoietin, oxidative metabolism and dialysis. Nephron 86(4): 544
Milutinovic, S.; Milutinovic, E.; Plavljanic, D.; Kusec, V. 2001: Erythropoietin-induced hypertension in dialyzed uremics is influenced by glycosylation patterns of the molecule. Nephrology Dialysis Transplantation 16(6): A91
King, D.; Schneider, G.B. 2000: Erythropoietin-inducible, erythroid-specific DNA construct. Official Gazette of the United States Patent and Trademark Office Patents 1240(4)
Weiss, S.; Sorokan, S.T.dd 2000: Erythropoietin-mediated neurogenesis. Official Gazette of the United States Patent and Trademark Office Patents 1241(4)
Tong, Q.; Chu, X.; Cheung, J.Y.; Barber, D.L.; Birnbaumer, L.; Miller, B.A. 2004: Erythropoietin-modulated calcium influx through TRPC2 is mediated by phospholipase C and IP3R. Biophysical Journal 86(1): 25a
Kawai, H.; Kojima, M.; Yokota, M.; Iguchi, H.; Wakasugi, H.; Jimi, A.; Funakoshi, A. 2000: Erythropoietin-producing pancreatic ductal adenocarcinoma. Pancreas 21(4): 427-429
Migliaccio, Giovanni; Di Giacomo, Viviana; Matteucci, Alessandro; Stellacci, Emilia; Battistini, Angela; Di Pietro, Roberta; Capitani, Silvano; Cocco, Lucio; Migliaccio, Anna Rita 2003: Erythropoietin-specific signal transduction in primary human erythroblasts. Blood 102(11): 165b
Abdel, Aaty T.; Rizk, M.M.; El Hassafi, Abadir A. 2001: Erythropoitein level in diabetics with and without neuropathy Relation to anaemia and metabolic control. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S255
Owen, D.; Taylor, M.; Walton, T.J.H.; Cavieres, J.D. 2000: Erythrosin isothiocyanate, as well as FITC, can modify all alphabeta protomers of membrane-bound Na,K-ATPase. Biophysical Journal 78(1 Part 2): 77A
Srivastava, A.; Kurpad, C.; Yoder, M.C. 2000: Erythroviruses as gene transfer vehicles. Contributions to Microbiology 4: 133-148
Kumar, E.S.S.nthosh; Chitra, C.R.; Shanavaskhan, A.E. 2002: Erythroxylum lanceolatum Walp and Vernonia peninsularis var kodayarensis Henry and Gopalan New records for Kerala. Journal of Economic and Taxonomic Botany 25(3): 599-601
Tsianos, E.V.; Christodoulou, D.K.; Katsanos, K.H.; Tziallas, C.; Seferiadis, K. 2000: Erytrhopoietin, ferritin and iron in inflammatory bowel disease. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1373
Romero, M.; Viera, N.; Mosquera, J. 1999: Erytrogenic toxin type B and its precursor isolated from nephritogenic streptococci modulate apoptosis and increase proliferation of human leukocytes. Nephrology Dialysis Transplantation 14(9): A40
Pos, F.J.; Hulshof, M.C.; Van Tienhoven, G.T.; Koedooder, C.; Gonzalez Gonzalez, D. 2001: Escalated concomitant boost radiotherapy in bladder cancer. International Journal of Radiation Oncology Biology Physics 51(3 Suppl 1): 291
Mitchell, P.; Basser, R.; Ng, S.; Gibbs, P.; Chipman, M.; Grigg, A.; Gargano, J.; Riva, A.; Appia, F.; Green, M. 1999: Escalated dose docetaxel with G-CSF support in patients with solid tumours. European Journal of Cancer 35(Suppl 4): S288
Knauf, W.U.; Fischer, J.; Thiel, E.; Freund, M. 2000: Escalating doses of 2-CDA in the treatment of relapsed adult acute lymphoblastic leukaemia. Onkologie 23(Sonderheft 7): 141
Trudeau, M.E.; Crump, M.R.; Latreille, J.; Pritchard, K.I.; Palmer, M.; Tu, D.; Shepherd, L.; Shear, N.; Shapiro, L.; Oldfield, S.; Burnell, M.; Vandenberg, T.A.; Gelmon, K.A.; Blackstein, M.E.; Noel, D. 2000: Escalating doses of docetaxel and epirubicin as first line therapy for metastatic breast cancer A phase I/II study of the National Cancer Institute of Canada - Clinical Trials Group. Breast Cancer Research and Treatment 64(1): 124
Callander, N.S.; Freytes, C.O.; Walsh, T.; Ochoa, L.; Tran, H.; Nguyen, J.; Primeaux, S. 2003: Escalating doses of intravenous busulfan with a fixed dose of melphalan as a preparative regimen for patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Blood 102(11): 703a
Khaleeli, E.; Niemann, J.T.; Walker, R.G.; Rosborough, J.P. 2003: Escalating energy is more effective than fixed energy defibrillation for ischemically induced ventricular fibrillation. Journal of the American College of Cardiology 41(6 Suppl A): 350A
Cursiefen, S.; Flachenecker, P.; Toyka, K.V.; Rieckmann, P. 2000: Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosis. European Neurology 43(3): 186-187
Kiho, K.; Harvell, D. 2001: Escalating impacts of marine epizootics and the role of a changing environment Insights from a coral-fungus pathosystem. Ecological Society of America Annual Meeting Abstracts 86: 22
Dulude, H.; Lawrence, B.; Marbury, T.; Odland, M.; Kaplan, M.; Hoggard, J.G.; Ploth, D.; Teichman, S.L.; Neale, A.; Castaigne, J.P. 2001: Escalating single doses of CJC-1004, a locally acting antithrombotic agent in hemodialysis patients with vascular access occlusion. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 287A
Danaceau, J.P.; Day, J.E.; Smeal, S.J.; Deering, C.E.; Fleckenstein, A.E.; Wikins, D.G. 2004: Escalating-dose methamphetamine pretreatment prior to a multiple high-dose challenge Persistence of protection from monoaminergic deficits. FASEB Journal 18(4-5): Abstract 398
Dietl, G.P.; Alexander, R.R.; Bien, W.F. 2000: Escalation in Late Cretaceous-early Paleocene oysters from the Atlantic Coastal Plain. Paleobiology 26(2): 215-237
Lynskey, M.T.; Heath, A.C.; Bucholz, K.K.; Slutske, W.S.; Madden, P.A.F.; Nelson, E.C.; Statham, D.J.; Martin, N.G. 2002: Escalation of illicit drug use in early-onset cannabis users versus co-twin controls. Drug and Alcohol Dependence 66(Suppl 1): S108
Suzuki, G.; Kubokawa, K. 1999: Escape and swimming responses of amphioxus to the light, sound and touch stimuli. Zoological Science 16(Suppl ): 56
Hiraguchi, T.; Takahata, M.; Yamaguchi, T. 2001: Escape behavior elicited by hindwing mechanosensory stimulus in cricket. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 130A(4): 879
Camp, E.A.; Gaffin, D.D. 1999: Escape behavior mediated by negative phototaxis in the scorpion Paruroctonus utahensis. Journal of Arachnology 27(3): 679-684
Stiebel, H. 1999: Escape diving of Actitis hypoleucus at the presence of Accipiter nisus. Vogelkundliche Hefte Edertal 25: 107-108
Verbalis, J.G. 2001: Escape from antidiuresis: a good story. Kidney International 60(4): 1608-1610
Wang, X.; Masilamani, S.; Knepper, M.A. 1999: Escape from the Na-retaining action of aldosterone is associated with a selective decrease in the renal abundance of the thiazide-sensitive Na-Cl cotransporter. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 465A
Patel, D.D. 2001: Escape from tolerance in the human X-linked autoimmunity-allergic disregulation syndrome and the Scurfy mouse. Journal of Clinical Investigation 107(2): 155-157
Munro, J.L.; Sary, Z.; Gell, F.R. 2001: Escape gaps An option for the management of Caribbean trap fisheries. Anonymous Proceedings of the Gulf and Caribbean Fisheries Institute Volume 54 : 28-40
Pawelec, G.; Heinzel, S.; Kiessling, R.; Müller, L.; Ouyang, Q.; Zeuthen, J. 2000: Escape mechanisms in tumor immunity: a year 2000 update. Critical Reviews in Oncogenesis 11(2): 97-133
Bakker, F.; Burger, R.; Baum, W.; Guenther, A.; Gramatzki, M. 2003: Escape mechanisms of human plasmacytoma cells in a xenograft SCID mouse model. Blood 102(11): 929a
Jouault, T.; Ombetta, S.I.; Trinel, P.A.; Poulain, D. 2001: Escape of Candida albicans from phagocytes through regulation of ERK signaling pathway. Mycoses 44(Suppl 1): 35-36
Udayagiri, S.; Welter, S.C. 2000: Escape of Lygus hesperus eggs from parasitism by Anaphes iole in strawberries Plant structure effects. Biological Control 17(3): 234-242
Yasutomo, K. 2003: Escape of a malaria parasite from T cell immunity by activation of CD4+, CD25+ regulatory T cells. Bioscience Reports 23(1): 45
Brock, M.W.; Gilly, W.F. 2000: Escape of an organic Kv1 blocker from enclosure in the channel cavity. Biophysical Journal 78(1 Part 2): 94A
Mitchell, C.E.; Power, A.G. 2002: Escape of pathogens by introduced plant species. Ecological Society of America Annual Meeting Abstracts 87: 214-215
Eidietis, L. 2001: Escape response of Rana sylvatica and Rana clamitans tadpoles. American Zoologist 41(6): 1641-1642
Wesp, H.M.; Gibb, A.C. 2000: Escape response performance in the larval razorback sucker, Xyrauchen texanus. American Zoologist 40(6): 1255-1256
Born, E.W.; Riget, F.F.; Dietz, R.; Andriashek, D. 1999: Escape responses of hauled out ringed seals to aircraft disturbance. Polar Biology 21(3): 171-178
Maunder, R.G.; Moskovitz, D.N.; Cohen, Z.; Mcleod, R.S.; Macrae, H.M. 1999: Escape-avoidance, self-control and accepting responsibility are negatively associated with quality of life outcome of inflammatory bowel disease surgery. Gastroenterology 116(4 Part 2): A772
Dremiere, P.Y.; Fiorentini, L.; Cosimi, G.; Leonori, I.; Sala, A.; Spagnolo, A. 1999: Escapement from the main body of the bottom trawl used for the Mediterranean international trawl survey. Aquatic Living Resources 12(3): 207-217
Kareiva, P. 2000: Escaping past legacies to promote the recovery of salmon A cumulative risk analysis. AAAS Annual Meeting and Science Innovation Exposition 166: A38, February 17-22
Zhang, W.; Remenyik, E.; Zelterman, D.; Brash, D.E.; Wikonkal, N.M. 2001: Escaping the stem cell compartment: sustained UVB exposure allows p53-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations. Proceedings of the National Academy of Sciences of the United States of America 98(24): 13948-13953
Marmor, M.F.; Wagenaar, W.A.; Escher, M.C.; Wagenaar, J.W. 2003: Escher and the ophthalmologist. Survey of Ophthalmology 48(3): 356-361
Romeo, T. 2001: Escherichia coli CSRB gene and RNA encoded thereby. Official Gazette of the United States Patent and Trademark Office Patents 1246(2)
Shinkai, A.; Patel, P.H.; Loeb, L.A. 2001: Escherichia coli DNA polymerase I The conserved active site motif A is highly mutable. FASEB Journal 15(4): A522
Gilligan, P.H. 1999: Escherichia coli. EAEC, EHEC, EIEC, ETEC. Clinics in Laboratory Medicine 19(3): 505-521
Trchounian, A. 2003: Escherichia coli F0F1-ATP synthase under fermentation Association with secondary solute transporters and/or enzymes of anaerobic oxidation-reduction. FEMS Congress of European Microbiologists Abstract Book 1: 356-357
Bogosian, G. 1999: Escherichia coli K-12 strains for production of recombinant proteins. Official Gazette of the United States Patent and Trademark Office Patents 1225(1)
Chapman, P.A. 1999: Escherichia coli O157 14 years experience in Sheffield, UK. Stewart, C S , Flint, H J Escherichia coli O157 in farm animals 99-119
Beutin, L. 1999: Escherichia coli O157 and other types of verocytotoxigenic E coli isolated from humans, animals and food in Germany. Stewart, C S , Flint, H J Escherichia coli O157 in farm animals 121-145
Chapman, P. 2000: Escherichia coli O157 in Sheffield. Research in Veterinary Science 68(Suppl A): 12
Rasmussen, M.A.; Wickman, T.L.; Cray, W.C.Jr; Casey, T.A. 1999: Escherichia coli O157H7 and the rumen environment. Stewart, C S , Flint, H J Escherichia coli O157 in farm animals 39-49
Tarr, P.I.; Bilge, S.S.; Besser, T.E.; Vary, J.C. 2000: Escherichia coli O157H7 epithelial adhesion and vaccine. Official Gazette of the United States Patent and Trademark Office Patents 1232(3)
Haack, J.P.; Jelacic, S.; Besser, T.E.; Mckee, G.; Kirk, D.; Tarr, P.I. 2000: Escherichia coli O157H7 exposure suggested by a serologic survey in Wyoming and Seattle. Journal of Investigative Medicine 48(1): 57A
Besser, R.E.; Griffin, P.M.; Slutsker, L. 1999: Escherichia coli O157:H7 gastroenteritis and the hemolytic uremic syndrome: an emerging infectious disease. Annual Review of Medicine 50: 355-367
Fathi, S.; Hussein, A.; Essa, H.; Ahmed, A.; Thabet, A. 2002: Escherichia coli O157H7 in fresh chicken cuts and offals collected from a chicken slaughtering plant in Assiut, Upper Egypt. Poultry Science 81(Suppl 1): 85
Riley, M.R.; Lee, K.K. 2004: Escherichia coli O157:H7-associated hemolytic uremic syndrome and acute hepatocellular cholestasis: a case report. Journal of Pediatric Gastroenterology and Nutrition 38(3): 352-354
Kozakova, H.; Cukrowska, B.; Sinkora, J.; Rehakova, Z.; Kolinska, J.; Tlaskalova Hogenava, H. 2000: Escherichia coli O86 affects brush border enzyme activities and B-cell response in monoassociated piglets. Scandinavian Journal of Immunology 52(4): 449-450
Wachi, M. 2001: Escherichia coli RNase G. Nippon Nogeikagaku Kaishi 75(2): 121-127
Edberg, S.C.; Rice, E.W.; Karlin, R.J.; Allen, M.J. 2000: Escherichia coli: the best biological drinking water indicator for public health protection. Symposium Series 29: 106s-116s
Notermans, S.H.W. 2000: Escherichia coli What next?. Society for Applied Microbiology Symposium Series 29: 11S
Stewart, J.R.; Thompson, B.C.; Webster, L.F.; Scott, G.I. 2000: Escherichia coli and coliphage analyses to differentiate pollution sources in surface waters of South Carolina. Abstracts of the General Meeting of the American Society for Microbiology 100: 608
Zechner, E.L.; Reisner, A.; Schembri, M.A.; Molin, S. 2002: Escherichia coli biofilm architecture induced by derepressed IncF plasmids. Plasmid 48(3): 289-290
Griffith, M.; Gietz, R.Daniel. 2003: Escherichia coli endA deletion strain for use in two-hybrid shuttle vector selection. Biotechniques 35(2): 272-4 276 278
Woodruff, E.S.; Probert, W.S.; Biggerstaff, B.J.; Johnson, B.J.B. 2000: Escherichia coli expressing a Borrelia burgdorferi fibronectin-binding polypeptide invade epithelial and skin fibroblast cells in vitro. Abstracts of the General Meeting of the American Society for Microbiology 100: 109
Perez Boada, M.; Doyle, W.A.; Ruiz Duenas, F.J.; Martinez, M.J.; Martinez, A.T.; Smith, A.T. 2001: Escherichia coli expression and in vitro folding optimization of Pleurotus eryngii peroxidase. Biochemical Society Transactions 29(1): A35
Bagramyan, K.; Mnatsakanyan, N.; Poladian, A.; Vassilian, A.; Trchounian, A. 2000: Escherichia coli formate hydrogenylase pathways A requirement of the F0F1 ATP synthase for the activity of hydrogenase. Biochemical Society Transactions 28(5): A187
Yep, A.; Ballicora, M.A.; Preiss, J. 2003: Escherichia coli glycogen synthase Function of cysteine residue379. Abstracts of Papers American Chemical Society 226(1-2): CARB 76
Mahishi, L.H.; Tripathi, G.; Ramchander, T.V.N.; Rawal, S.K.shen 2004: Escherichia coli having accession No PTA 1579 and its use to produce polyhydroxybutyrate. Official Gazette of the United States Patent and Trademark Office Patents 1283(5)
Biermann, C.; Zitzer, A.; Schulte, B.; Gerhards, A.; Stanley, P.; Hughes, C.; Koronakis, V.; Bhakdi, S.; Palmer, M. 2000: Escherichia coli hemolysin Interaction with cell membranes studied by cysteine scanning mutagenesis. IJMM International Journal of Medical Microbiology 290(4-5, Suppl 30): A19
Jahnukainen, T.; Chen, M.; Jahnukainen, K.; Chrysis, D.; Ahlbom, E.; Celsi, G. 2000: Escherichia coli induces apoptosis in LLC-PK1 cells. Nephrology Dialysis Transplantation 15(9): A9
Belcher, E.; Evans, T.W.; Sriskandan, S.; Mitchell, J.A. 2003: Escherichia coli induces nitric oxide release in cardiovascular tissue via a toll like receptor 4-independent pathway. British Journal of Pharmacology 138(Proceedings Suppl): 32P
Carneiro, L.A.M.; Lins, M.C.; Queiroz, M.L.P. 1999: Escherichia coli isolated from pasteurized milk commercialized in the city of Rio de Janeiro Serogroup , antimicrobial resistance, and adherence properties to HEp-2 cells. Abstracts of the General Meeting of the American Society for Microbiology 99: 519
Varela, M.F.; Wilson, T.H.; Brooker, R.J.; Rondon Rivera, V.; Shepherd, S.; Dehne, T.A.; Rector, A.C. 1999: Escherichia coli lactose carrier mutants with altered sugar recognition. Abstracts of the General Meeting of the American Society for Microbiology 99: 417
Rensing, C.; Grass, G. 2003: Escherichia coli mechanisms of copper homeostasis in a changing environment. Fems Microbiology Reviews 27(2-3): 197-213
Applebaum, G.D.; Donovan, S. 1999: Escherichia coli meningitis in a human immunodeficiency virus-infected man after outpatient hemorrhoidectomy. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 29(2): 448-449
Liu, L.-F.; Hsieh, C.-H.; Liu, P.-F.; Tsai, S.-P.; Tam, M.F. 2004: Escherichia coli methionine aminopeptidase with Tyr168 to alanine substitution can improve the N-terminal processing of recombinant proteins with valine at the penultimate position. Analytical Biochemistry 329(2): 345-347
Horst, J.P.; Wu, T.H.; Marinus, M.G. 1999: Escherichia coli mutator genes. Trends in Microbiology 7(1): 29-36
Johnson, J.R. 2002: Escherichia coli pathogenicity island-like domains. Infection and Immunity 70(12): 7185; Author Reply 7185-6
Kaper, J.B.; Jarvis, K. 2003: Escherichia coli secreted protein B. Official Gazette of the United States Patent and Trademark Office Patents 1275(3)
Boudeau, J.; Rich, C.; Colombel, J.F.; Darfeuille Michaud, A. 2001: Escherichia coli strain Nissle 1917 inhibits adhesion to and invasion of intestinal epithelial cells by adherent-invasive E coli isolated from a Crohns disease patient. Gastroenterology 120(5 Suppl 1): A 190
Debabov, V.G.; Kozlov, J.I.; Khurges, E.M.; Livshits, V.A.; Zhdanova, N.I.; Gusyatiner, M.M.; Sokolov, A.K.; Bachina, T.A.; Yankovsky, N.K.; Tsygankov, J.D.; Christoserdov, A.J.; Plotnikova, T. 2001: Escherichia coli strain and method for producing L-threonine. Official Gazette of the United States Patent and Trademark Office Patents 1251(1)
Halloran, Z.; Keudell, K.; Romano, M. 2001: Escherichia coli strain selection in calves as determined by multilocus enzyme analysis. Transactions of the Illinois State Academy of Science 94(Suppl): 91
Cha, M.K.; Kim, W.C.; Kim, I.H. 2003: Escherichia coli thiol peroxidase as a heat-shock inducible protein acts as an antioxidant against a cellular oxidative damage caused by heat shock. Free Radical Biology and Medicine 35(Suppl 1): S67
Kim, K.S. 2001: Escherichia coli translocation at the blood-brain barrier. Infection and Immunity 69(9): 5217-5222
Tieng, V.; Le Bouguenec, C.; Du Merle, L.; Bertheau, P.; Desreumaux, P.; Janin, A.; Charron, D.; Toubert, A. 2002: Escherichia coli triggers expression of MICA molecules on epithelial cells A novel pathway of innate immune response. European Journal of Immunogenetics 29(2): 130
Zakharyan, E.; Trchounian, A. 2000: Escherichia coli uses a distinct K+ uptake system and/or a different mode in its operating depended on growth pH. Biochemical Society Transactions 28(5): A395
Kapoor, R.; Adenwala, T.; Liatsikos, E.N.; Smith, A.D.; Singhal, P.K. 2000: Escherichia coli-human uroepithelial cell interaction products enhance migration and transformation of fibroblasts. Journal of Urology 163(4 Suppl): 11
Preston, R.E. 2000: Eschscholzia rhombipetala E Greene. Madrono 47(2): 138
Waugh, J.; Goa, K.L. 2003: Escitalopram : a review of its use in the management of major depressive and anxiety disorders. Cns Drugs 17(5): 343-362
Klein, N.; Wiesegger, G.; Winkler, D.; Attarbaschi, T.; Mossaheb, N.; Kasper, S.; Tauscher, J. 2003: Escitalopram for treatment of depression and anxiety disorder in adult outpatients. European Neuropsychopharmacology 13(Suppl 4): S237-S238
Greenblatt, D.J.; Von Moltke, L.L.; Giancarlo, G.M.; Harmatz, J.S.; Shader, R.I. 2001: Escitalopram metabolism in vitro. Clinical Pharmacology and Therapeutics 69(2): P49
Sorbera, L.A.; Revel, L.; Martin, L.; Castaner, J. 2001: Escitalopram oxalate Antidepressant 5-HT reuptake inhibitor. Drugs of the Future 26(2): 115-120
Menard, F.; Colonna, L.; Andersen, H.F. 2003: Escitalopram versus citalopram More efficacious and well tolerated in long-term treatment of moderately depressed patients. European Neuropsychopharmacology 13(Suppl 4): S215
Montgomery, S.A.; Francois, C.; Despiegel, N. 2003: Escitalopram versus placebo in social anxiety disorder Better effectiveness, lower costs and improved quality of life. European Neuropsychopharmacology 13(Suppl 4): S369-S370
Lindgren, K.N.; Bangh, S.A.; Ling, L.; Stremski, E.; Mueller, C. 2003: Escitalopram, a review of adverse effects in overdose reported to select regional poison centers. Journal of Toxicology. Clinical Toxicology 41(5): 658
Mateu, J. 2003: Escolatrechus bolivianus gen n, sp n of Trechinae from Bolivia. Elytron (Barcelona) 16: 23-28
Bal Tembe, S.; Vijaya Kumar, E.K.teswara Satya; Bhagwan Deore, V.; Sanjay Joshi, K. 2000: Esculentin A and esculentin B, a process for their preparation, and their use in the manufacture of medicaments. Official Gazette of the United States Patent and Trademark Office Patents 1237(4)
James, A.; Armstrong, L. 1999: Esculetin derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1229(4)
Pfeffer, P.L.; Davey, H.; Beaton, A.; L'huillier, P. 2003: Ese2 is crucial for the extraembryonic ectoderm. Developmental Biology 259(2): 529-530
Takahashi, M.; Crane, P.R.; Ando, H. 1999: Esgueiria futabensis sp nov, a new angiosperm flower from the Upper Cretaceous of northeastern Honshu, Japan. Paleontological Research 3(2): 81-87
Landry, F.; Murphy, F.M.; Sharpe, I.D.; Fikart, A.; Chapman, P.M. 2000: Eskay Creek mine environmental effects monitoring program. Canadian Technical Report of Fisheries and Aquatic Sciences 2331: 109
Guenther, C.; Modry, D.; Koshal, A.; Finegan, B.A. 1999: Esmolol bolus as a part of anaesthetic induction for control of tachycardia and hypertension in coronary artery bypass graft patients. Canadian Journal of Anaesthesia 46(5 Part 2): A36
Fan, L.; Friedman, D.M.; Woods Brown, A.; Fisher, M.; Krilov, L.; Quyyumi, A.; Ovadia, M. 2000: Esmolol causes paradoxical supine tachycardia response in a subgroup of pediatric chronic fatigue Disturbance of adrenergic ligand-receptor pathway in blood pressure control?. Journal of the American College of Cardiology 35(2 Suppl A): 331A
Liu, J.; Pejaver, S.K.; Owoo, G. 2003: Esmolol formulation. Official Gazette of the United States Patent and Trademark Office Patents 1268(1)
Hübler, M.; Litz, R.J.; Albrecht, D.M. 2001: Esmolol is not an alternative to remifentanil for fast-track outpatient gynecologic laparoscopic surgery. Anesthesia and Analgesia 93(1): 241-242
Atlee, J.L.; Dhamee, M.S.; Olund, T.L.; George, V. 1999: Esmolol, nicardipine or combination to prevent blood pressure and heart rate increase after intubation. Anesthesiology 91(3A): A169
Spencer, C.M.; Faulds, D. 2000: Esomeprazole. Drugs 60(2): 321-329; Discussion: 330-331
Wilder Smith, C.H.; Nilsson Pieschl, C.; Lundgren, M.; Ahlbom, H.; Rohss, K. 2003: Esomeprazole 20 mg administered as a 30-minute infusion provides a similar level of acid control as oral administration in healthy subjects. American Journal of Gastroenterology 98(9 Suppl): S21
Lauritsen, K.; Junghard, O.; Eklund, S. 2002: Esomeprazole 20 mg compared with lansoprazole 15 mg for maintenance therapy in patients with healed reflux oesophagitis. Gut 50(Suppl 2): A121-A122
Talley, N.J.; Lauristen, K.; Tunturi Hihnala, H.; Lind, T.; Moum, B.; Bang, C.J.; Schulz, T.B.; Omland, T.M.; Delle, M.S.; Junghard, O. 2000: Esomeprazole 20mg maintains symptom control in endoscopy-negative GERD A randomized placebo-controlled trial of on-demand therapy for 6 months. Gastroenterology 118(4 Suppl 2 Pt 1): A21
Wilder Smith, C.; Bondarov, P.; Hallerback, B.; Nilsson Pieschl, C.; Ahlbom, H.; Rohss, K. 2003: Esomeprazole 40 mg intravenous provides faster and more effective acid control than pantoprazole 40 mg intravenous after first dose and 5 days. American Journal of Gastroenterology 98(9 Suppl): S24-S25
Wilder Smith, C.; Rohss, K.M.; Claar Nilsson, C.; Lundin, C. 2002: Esomeprazole 40 mg provides faster and more effective acid control than lansoprazole 30 mg in patients with symptoms of gastroesophageal reflux disease. Gastroenterology 122(4 Suppl 1): A-200
Rohss, K.; Claar Nilsson, C.; Rydholm, H.; Nyman, L. 2000: Esomeprazole 40 mg provides more effective acid control than lansoprazole 30 mg. Gastroenterology 118(4 Suppl 2 Pt 1): A20
Rohss, K.; Lundin, C.; Rydholm, H.; Nyman, L. 2000: Esomeprazole 40 mg provides more effective acid control than omeprazole 40 mg. American Journal of Gastroenterology 95(9): 2432-2433
Wilder Smith, C.; Rohss, K.; Lundin, C.; Rydholm, H. 2000: Esomeprazole 40 mg provides more effective acid control than pantoprazole 40 mg. Gastroenterology 118(4 Suppl 2 Pt 1): A22-A23
Rohss, K.; Wilder Smith, C.H.; Claar Nilsson, C.; Lundin, C.; Hasselgren, G. 2001: Esomeprazole 40 mg provides more effective acid control than standard doses of all other proton pump inhibitors. Gastroenterology 120(5 Suppl 1): A 419
Schneider, H.; Van Rensburg, C.; Schmidt, S. 2003: Esomeprazole 40 mg provides safe and effective healing of erosive esophagitis whether administered as an intravenous injection, an IV infusion or orally. American Journal of Gastroenterology 98(9 Suppl): S11
Talley, N.J.; Venables, T.L.; Green, J.R.; Armstrong, D.; O'kane, K.P.; Giaffer, M.H.; Bardhan, K.D.; Carlsson, R.; Chen, S.; Hasselgren, G. 2000: Esomeprazole 40mg and 20mg is efficacious in the long-term management of patients with endoscopy-negative GERD A placebo-controlled trial of on-demand therapy for 6 months. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A658
Fass, R.; Traxler, B.M.; Thomas, S.; Sostek, M.B. 2003: Esomeprazole 40mg once daily and lansoprazole 30mg twice daily for heartburn symptoms in patients with resistant GERD. American Journal of Gastroenterology 98(9 Suppl): S35
Scott, L.J.; Dunn, C.J.; Mallarkey, G.; Sharpe, M. 2002: Esomeprazole: a review of its use in the management of acid-related disorders. Drugs 62(10): 1503-1538
Sostek, M.B.; Chen, Y.; Skammer, W.; Winter, H.; Zhao, J.; Andersson, T. 2002: Esomeprazole Nasogastric tube administration of the contents of an opened capsule suspended in water compared with oral administration in healthy volunteers. Pharmacotherapy 22(10): 1339
Johnson, D.A.; Hoyle, P.E.; Traxler, B.M.; Levine, D.; Lauritsen, K. 2003: Esomeprazole as maintenance therapy in erosive esophagitis A quantitative assessment of efficacy using an evidence-based approach. American Journal of Gastroenterology 98(9 Suppl): S34
Fennerty, M.B.; Laine, L.A.; Sugg, J.E.; Zuckerman, S.; Levine, J.G. 2000: Esomeprazole based triple therapy is more effective than dual therapy for eradication of H pylori. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A495
White, C.M.; Kalus, J.; Quercia, R.; Fortier, C.; Piotrowski, A.; Roach, A.; Sostek, M.B. 2002: Esomeprazole capsule contents suspended in water can be efficiently delivered through nasogastric and gastrostomy tubes. Pharmacotherapy 22(10): 1338-1339
Lauritsen, K.; Junghard, O.; Levine, D. 2003: Esomeprazole compared with lansoprazole for maintaining healed erosive esophagitis in patients with hiatus hernia. American Journal of Gastroenterology 98(9 Suppl): S18
Vakil, N.B.; Shaker, R.; Hwang, C.; D'amico, D.; Hamelin, B. 2000: Esomeprazole is effective as maintenance therapy in GERD patients with healed erosive esophagitis. Gastroenterology 118(4 Suppl 2 Pt 1): A22
Richter, J.E.; Kahrilas, P.J.; Hwang, C.; Marino, V.; Hamelin, B. 2000: Esomeprazole is superior to omeprazole for the healing of erosive esophagitis in GERD patients. Gastroenterology 118(4 Suppl 2 Pt 1): A20
Graul, A.; Castaner, R.; Castaner, J. 1999: Esomeprazole magnesium H+/K+-ATPase inhibitor antiulcer, treatment of GERD. Drugs of the Future 24(11): 1178-1183
Anonymous 2000: Esomeprazole magnesium, H-199/18, Nexium Treatment of GERD, antiulcer, anti-helicobacter pylori, H+/K+-ATPase inhibitor EN 272598. Drugs of the Future 25(11): 1190-1192
Scheiman, J.M.; Yeomans, N.; Hawkey, C.J.; Talley, N.J.; Sung, J.; Jones, R. 2003: Esomeprazole maintains control of upper GI symptoms in patients on NSAID therapy. American Journal of Gastroenterology 98(9 Suppl): S3
Andersson, T.; Magner, D.J.; Patel, J.B.; Rogers, P.; Levine, J.G. 2000: Esomeprazole open capsule mixed with applesauce is bioequivalent to the intact capsule when administered to healthy volunteers. American Journal of Gastroenterology 95(9): 2448
Johnson, D.A.; Roach, A.; Karlsson, A.A.S.; Carlsson, A.S.; Behr, D. 2002: Esomeprazole pellets are stable following in vitro suspension in common beverages. Pharmacotherapy 22(10): 1334
Katz, P.O.; Castell, D.O.; Chen, Y.; Sostek, M.B. 2003: Esomeprazole provides highly effective acid control that is equally well maintained during sleep and active periods. American Journal of Gastroenterology 98(9 Suppl): S15
Lind, T.; Kyleback, A.; Rydberg, L.; Jonsson, A.; Andersson, T.; Hasselgren, G.; Rohss, K. 2000: Esomeprazole provides improved acid control vs omeprazole in patients with symptoms of GERD. Gastroenterology 118(4 Suppl 2 Pt 1): A18
Scheiman, J.M.; Yeomans, N.; Hawkey, C.J.; Talley, N.J.; Gothe, L.; Sung, J.; Jones, R.; Naesdal, J. 2003: Esomeprazole reduces gastric and duodenal ulcer development among high risk NSAID users. American Journal of Gastroenterology 98(9 Suppl): S52
Yeomans, N.; Scheiman, J.; Sung, J.; Talley, N.J.; Jones, R.; Hawkey, C.J. 2003: Esomeprazole relieves NSAID-associated upper GI symptoms in patients taking either continuous COX-2 selective NSAIDs or non-selective NSAIDs. American Journal of Gastroenterology 98(9 Suppl): S46
Hassan Alin, M.; Niazi, M.; Rohss, K.; Lagerstrom, P.O.of 2000: Esomeprazole, the S-isomer of omeprazole, is optically stable in humans. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1244-AGA A1245
Miehlke, S.; Schneider Brachert, W.; Baestlein, E.; Ebert, S.; Kirsch, C.; Haferland, C.; Buchner, M.; Neumeyer, M.; Vieth, M.; Stolte, M.; Lehn, N.; Bayerdoerffer, E. 2003: Esomeprazole-based triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance A prospective, randomized, multicenter Trial. Alimentary Pharmacology and Therapeutics 18(8): 799-804, 15th October
Pehl, C.; Keller, J.; Merio, R.; Stacher, G. 2003: Esophageal 24 hour-ph metry. Zeitschrift fuer Gastroenterologie 41(6): 545-556
Miller, G.L.; Kleiner, D.M. 2002: Esophageal Tracheal Combitube intubation and football equipment. Medicine and Science in Sports and Exercise 34(5 Suppl): S102
Valenzuela, J.E.; Fernandez, M.; Perez, A.; Ribalta, G. 1999: Esophageal abnormalities that are associated with reflux laryngitis. Gastroenterology 116(4 Part 2): A342-A343
Tintillier, M.; Chaput, Aé.; Kirch, L.; Martinet, J-Paul.; Pochet, J-Michel.; Cuvelier, C. 2004: Esophageal abscess complicating endoscopic treatment of refractory gastroesophageal reflux disease by Enteryx injection: a first case report. American Journal of Gastroenterology 99(9): 1856-1858